{"content":"<li class=\"n-box-item date-title\" data-end=\"1384318799\" data-start=\"1384232400\" data-txt=\"Friday, December 20, 2019\">Tuesday, November 12, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1408612\" data-ts=\"1384298711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SB\" target=\"_blank\">SB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408612-safe-bulkers-in-5m-share-public-offering-1m-share-private-placement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safe Bulkers in 5M-share public offering, 1M-share private placement</a></h4><ul>\n<li>Safe Bulkers (NYSE:<a href=\"https://seekingalpha.com/symbol/SB\" title=\"Safe Bulkers Inc.\">SB</a>)<font color=\"red\"> -9.2%</font> AH after announcing a public offering of 5M common shares and a concurrent private placement of 1M common shares through an entity associated with CEO Polys Hajioannou.</li>\n<li>SB plans to use the proceeds for vessel acquisitions, capital expenditures, debt repayment and other general  corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408612\" data-linked=\"Safe Bulkers in 5M-share public offering, 1M-share private placement\" data-tweet=\"$SB - Safe Bulkers in 5M-share public offering, 1M-share private placement https://seekingalpha.com/news/1408612-safe-bulkers-in-5m-share-public-offering-1m-share-private-placement?source=tweet\" data-url=\"https://seekingalpha.com/news/1408612-safe-bulkers-in-5m-share-public-offering-1m-share-private-placement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408562\" data-ts=\"1384297100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTP\" target=\"_blank\">CHTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408562-chelsea-therapeutics-falls-6-percent-ah-on-follow-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chelsea Therapeutics falls 6% AH on follow-on</a></h4><ul>\n<li>Chelsea Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHTP\" title=\"Chelsea Therapeutics International, Ltd.\">CHTP</a>) shares add a <font color=\"red\">6% loss</font> AH to their <font color=\"red\">5.4% fall </font>during the regular trading day after the company announces it will offer common shares in a public follow-on. The amount has not been disclosed.</li>\n<li>Chelsea intends to use proceeds to fund its droxidopa program, including regulatory and initial commercialization activity.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408562\" data-linked=\"Chelsea Therapeutics falls 6% AH on follow-on\" data-tweet=\"$CHTP - Chelsea Therapeutics falls 6% AH on follow-on https://seekingalpha.com/news/1408562-chelsea-therapeutics-falls-6-percent-ah-on-follow-on?source=tweet\" data-url=\"https://seekingalpha.com/news/1408562-chelsea-therapeutics-falls-6-percent-ah-on-follow-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408502\" data-ts=\"1384296350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408502-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours Gainers / Losers</a></h4><ul>     <li><b>Top Gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/RLD' title='RealD Inc.'>RLD</a> <font color='green'>+20.0%</font>. <a href='https://seekingalpha.com/symbol/CALL' title='magicJack VocalTec Communications Ltd.'>CALL</a> <font color='green'>+13.1%</font>. <a href='https://seekingalpha.com/symbol/PEGA' title='Pegasystems Inc.'>PEGA</a> <font color='green'>+9.3%</font>. <a href='https://seekingalpha.com/symbol/PBPB' title='Potbelly Corporation'>PBPB</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/SINA' title='Sina Corporation'>SINA</a> <font color='green'>+3.6%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='red'>-28.2%</font>. <a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers Inc.'>SB</a> <font color='red'>-9.2%</font>. <a href='https://seekingalpha.com/symbol/BALT' title='Baltic Trading Limited'>BALT</a> <font color='red'>-8.2%</font>. SNTA <font color='red'>-6.1%</font>. NQ <font color='red'>-4.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1408502\" data-linked=\"After hours Gainers / Losers\" data-tweet=\"$RLD $CALL $PEGA - After hours Gainers / Losers https://seekingalpha.com/news/1408502-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1408502-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408422\" data-ts=\"1384295240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408422-sina-provides-strong-margin-figures-and-guidance-weibo-revenue-soars\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina provides strong margin figures and guidance; Weibo revenue soars</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> expects Q4 revenue of $190M-$194M, well above a $182.1M consensus. Ad revenue is expected to total $160M-$162M, up from a Q4 2012 level of $110.7M.</li>\n<li>Q3 ad sales rose 26% Y/Y to $151.6M; that's a faster growth rate than Q2's 17%. A major reason: Weibo ad sales jumped 46% Q/Q and 125% Y/Y to $43.7M.</li>\n<li>Non-ad revenue only rose 5% Y/Y to $28.4M, after growing 35% in Q2. The slowdown occurred even though Weibo value-added service revenue rose 26% Q/Q and 121% Y/Y to $9.7M.</li>\n<li>Gross margin jumped to 64% from 54% in Q2 and the year-ago period. Sina says its \"efforts to scale its core advertising business profitably\" are improving margins.</li>\n<li>Opex rose 23% Y/Y, slightly outpacing rev. growth of 21%. A 29% increase in R&amp;D spend to $36.6M had much to do with the increase.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> <font color=\"green\">+3.4%</font> AH. <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=121288&amp;p=irol-calendar\" target=\"_blank\">CC</a> at 8PM ET. <a href=\"https://seekingalpha.com/currents/post/1408182\" target=\"_blank\">Q3 results</a>, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408422\" data-linked=\"Sina provides strong margin figures and guidance; Weibo revenue soars\" data-tweet=\"$SINA - Sina provides strong margin figures and guidance; Weibo revenue soars https://seekingalpha.com/news/1408422-sina-provides-strong-margin-figures-and-guidance-weibo-revenue-soars?source=tweet\" data-url=\"https://seekingalpha.com/news/1408422-sina-provides-strong-margin-figures-and-guidance-weibo-revenue-soars\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408392\" data-ts=\"1384295096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEGA\" target=\"_blank\">PEGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408392-pegasystems-jumps-9_3-percent-ah-on-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pegasystems jumps 9.3% AH on Q3 beat</a></h4><ul>\n<li>Shares of Pegasystems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PEGA\" title=\"Pegasystems Inc.\">PEGA</a>) <font color=\"red\">jump 9.3%</font> AH after the company crushed expectations <a href=\"https://seekingalpha.com/currents/post/1408082\" target=\"_blank\">in Q3</a>.</li>\n<li>Revenue grew 20% Y/Y to $122M, driven by a 56.8% jump in licensing revenue to $44.8M.</li>\n<li>Opex grew 10.3% Y/Y to $70.1M in Q3.</li>\n<li>PR, <a href=\"http://www.media-server.com/m/p/32rmwaxd\" target=\"_blank\">Conference call</a> scheduled for 6pm ET</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408392\" data-linked=\"Pegasystems jumps 9.3% AH on Q3 beat\" data-tweet=\"$PEGA - Pegasystems jumps 9.3% AH on Q3 beat https://seekingalpha.com/news/1408392-pegasystems-jumps-9_3-percent-ah-on-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1408392-pegasystems-jumps-9_3-percent-ah-on-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408382\" data-ts=\"1384294962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408382-stillwater-mining-minus-1_5-percent-on-big-q3-earnings-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stillwater Mining -1.5% on big Q3 earnings loss</a></h4><ul>     <li>Stillwater Mining (SWC) <font color=\"red\">-1.5%</font> AH after posting a <a href=\"https://seekingalpha.com/currents/post/1407922\" target=\"_blank\">Q3 loss</a> of $1.69/share vs. a $0.04 loss in Q2 and $0.11 in earnings in the year-ago quarter.</li>     <li>SWC's Montana mines produced a total 124K oz. of palladium and platinum in Q3 vs. 127K oz. a year ago; production for the first nine months was 382.8K oz. vs. 381.2K oz. in the first nine months of 2012.</li>     <li>Raises 2013 production guidance to 505K-515K oz. of mined palladium and platinum vs. prior guidance of 500K; lowers expected full-year cash costs to $530-$540 per mined oz. from $560.</li>\n<li>Lowers 2013 capex guidance by ~13% to $125M-$135M  from the previous range of $145M-$155M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408382\" data-linked=\"Stillwater Mining -1.5% on big Q3 earnings loss\" data-tweet=\"$SBGL - Stillwater Mining -1.5% on big Q3 earnings loss https://seekingalpha.com/news/1408382-stillwater-mining-minus-1_5-percent-on-big-q3-earnings-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/1408382-stillwater-mining-minus-1_5-percent-on-big-q3-earnings-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408322\" data-ts=\"1384294327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRCW\" target=\"_blank\">YRCW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408322-yrc-worldwide-plunges-25_2-percent-ah-on-dismal-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YRC Worldwide plunges 25.2% AH on dismal Q3</a></h4><ul>\n<li>YRC Worldwide (NASDAQ:<a href=\"https://seekingalpha.com/symbol/YRCW\" title=\"YRC Worldwide, Inc.\">YRCW</a>) shares are taking a bath AH, <font color=\"red\">down 25.2%</font>, after the company's dismal <a href=\"https://seekingalpha.com/currents/post/1408012\" target=\"_blank\">Q3 report</a>.</li>\n<li>Operating income deteriorated further, falling 78.8% Y/Y to $5.8M. EBITDA fell 20.8% Y/Y to $62.4M. Net loss totaled -$4.45/share (shares currently trade at $6.98).</li>\n<li>CEO James Welch noted that results were \"hindered by declines in service, manpower shortages and declines in yield ... the YRC Freight network was 'out of cycle.'\"</li>\n<li>A sliver of silver lining: \"In October, service was within a couple of percentage points of where it was prior to the network optimization, and shipments per day were slightly higher than they were in October 2012, reversing negative trends,\" the CEO noted.</li>\n<li>No word has been provided on whether the company has come to an agreement with the Teamsters Union, which the CEO <a href=\"https://seekingalpha.com/currents/post/1401762\" target=\"_blank\">implored </a>earlier this week to make concessions. The market may be taking the silence as an ominous sign.</li>\n<li>The company had cash, cash equivalents, and a remaining loan facility of $233.7M at the end of the quarter. YRC burned $128.6M in the last 9 months.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408322\" data-linked=\"YRC Worldwide plunges 25.2% AH on dismal Q3\" data-tweet=\"$YRCW - YRC Worldwide plunges 25.2% AH on dismal Q3 https://seekingalpha.com/news/1408322-yrc-worldwide-plunges-25_2-percent-ah-on-dismal-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/1408322-yrc-worldwide-plunges-25_2-percent-ah-on-dismal-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408272\" data-ts=\"1384293487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408272-nqs-guidance-solid-but-gross-margin-drops-management-buying-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ&#39;s guidance solid, but gross margin drops; management buying stock</a></h4><ul>\n<li>NQ Mobile (NQ) expects Q4 revenue of $62M-$63M, above a $61.8M consensus. The Chinese mobile app developer also announces several execs, including its co-CEOs, COO, and CFO, have committed to collectively buying $3M worth of shares within six months of Nov. 15, as a show of faith following Muddy Waters' <a href=\"https://seekingalpha.com/currents/post/1353642\" target=\"_blank\">accusations</a>.</li>\n<li>NQ's Q3 mobile value-added service revenue (security apps and games) amounted to $26.9M (half of total revenue), nearly flat Q/Q but up 46% Y/Y. Enterprise mobility revenue (<a href=\"http://ir.nq.com/phoenix.zhtml?c=243152&amp;p=irol-newsArticle&amp;ID=1692569&amp;highlight=\" target=\"_blank\">NationSky</a>) soared 91% Q/Q and 243% Y/Y to $15.3M, and ad revenue doubled Q/Q to $11M.</li>\n<li>Q3 EPS was pressured by a decline in gross margin to 59.5% from 66.7% in Q2 and 69.2% a year ago; NQ attributes this to a mix shift towards lower-margin enterprise sales; NationSky had a gross margin of just 24.8%. Also, while revenue grew 31% Q/Q and 110% Y/Y, opex rose 31% Q/Q and 88% Y/Y.</li>\n<li>The company, which is fresh off raising $166M in a convertible debt offering, says it will continue looking for M&amp;A opportunities in \"related business areas.\"</li>\n<li>NQ <font color=\"red\">-2.2%</font> AH. <a href=\"http://www.media-server.com/m/p/q4x5s3pt\" target=\"_blank\">CC</a> at 8PM ET. <a href=\"https://seekingalpha.com/currents/post/1408102\" target=\"_blank\">Q3 results</a>, PR.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408272\" data-linked=\"NQ&#39;s guidance solid, but gross margin drops; management buying stock\" data-tweet=\"$LKM - NQ&#39;s guidance solid, but gross margin drops; management buying stock https://seekingalpha.com/news/1408272-nqs-guidance-solid-but-gross-margin-drops-management-buying-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/1408272-nqs-guidance-solid-but-gross-margin-drops-management-buying-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408232\" data-ts=\"1384293126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WX\" target=\"_blank\">WX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408232-wuxi-pharmatech-beats-raises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WuXi PharmaTech beats, raises</a></h4><ul>\n<li>WuXi PharmaTech (NYSE:<a href=\"https://seekingalpha.com/symbol/WX\" title=\"WuXi PharmaTech Inc.\">WX</a>) rallies <font color=\"green\">5%</font> AH on top of<font color=\"green\"> 4.5%</font> during the regular session.<br>\n</li>\n<li>Q3 revenue rises 16.6% Y/Y. Breakdown: Laboratory Services revenue +9.2% to $108.1M, Manufacturing Services revenue +43.6% to $38.6M.</li>\n<li>\"WuXi achieved solid, broad-based revenue growth and stable margins in the third quarter,\" CEO Ge Li says, adding that the company is \"also making the investments necessary to sustain growth.\"</li>\n<li>FY13 outlook: Adjusted earnings per ADS of $1.73-1.77 (versus previous guidance of $1.61-1.67) on sales of $574-578M (+15-16% Y/Y and versus previous guidance of $572-578M).</li>\n<li>FQ4 outlook: Adjusted earnings per ADS of $0.44-0.48 on revenue of $153-157M. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408232\" data-linked=\"WuXi PharmaTech beats, raises\" data-tweet=\"$WX - WuXi PharmaTech beats, raises https://seekingalpha.com/news/1408232-wuxi-pharmatech-beats-raises?source=tweet\" data-url=\"https://seekingalpha.com/news/1408232-wuxi-pharmatech-beats-raises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408202\" data-ts=\"1384292828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BALT\" target=\"_blank\">BALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408202-baltic-trading-falls-7_8-percent-ah-on-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baltic Trading falls 7.8% AH on public offering</a></h4><ul>\n<li>Baltic Trading (NYSE:<a href=\"https://seekingalpha.com/symbol/BALT\" title=\"Baltic Trading Limited\">BALT</a>) shares <font color=\"red\">tumble 7.8%</font> AH after the company announces</li>\n<li>it has commenced a public offering of stock.</li>\n<li>Baltic intends to use proceeds for future vessel acquisitions and/or working capital. In conjunction to the offering, the company discloses it has been in negotiations to purchase 2 Ultramax drybulk vessels for $56M. The company has the option to purchase 2 additional vessels for $28M each, which would be financed through the public offering. (<a href=\"http://biz.yahoo.com/e/131112/balt8-k.html\" target=\"_blank\">8-K</a>)</li>\n<li>\n<em>Deja vu</em>? Shares <font color=\"red\">fell 5.9%</font> AH in Sept. when the company <a href=\"https://seekingalpha.com/currents/post/1289902\" target=\"_blank\">announced</a> a 5.6M share follow-on.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1408202\" data-linked=\"Baltic Trading falls 7.8% AH on public offering\" data-tweet=\"$BALT - Baltic Trading falls 7.8% AH on public offering https://seekingalpha.com/news/1408202-baltic-trading-falls-7_8-percent-ah-on-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1408202-baltic-trading-falls-7_8-percent-ah-on-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1408002\" data-ts=\"1384291733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBPB\" target=\"_blank\">PBPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1408002-potbelly-higher-after-besting-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potbelly higher after besting estimates</a></h4><ul> <li>Potbelly (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PBPB\" title=\"Potbelly Corporation\">PBPB</a>) reports comparable store sales rose 2.5% during FQ3.</li> <li>Though comp growth came in unspectacular, the sandwich shop operator raised its guidance on revenue to provide something hearty for investors to bite on.</li> <li>PBPB <font color=\"green\">+5.7%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1408002\" data-linked=\"Potbelly higher after besting estimates\" data-tweet=\"$PBPB - Potbelly higher after besting estimates https://seekingalpha.com/news/1408002-potbelly-higher-after-besting-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1408002-potbelly-higher-after-besting-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407962\" data-ts=\"1384291301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBEPQ\" target=\"_blank\">BBEPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407962-breitburn-energy-in-15m-unit-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Breitburn Energy in 15M-unit public offering</a></h4><ul>\n<li>Breitburn Energy Partners (BBEP) <font color=\"red\">-3.7%</font> AH after announcing a public offering of 15M common units.</li>\n<li>BBEP says it intends to use the net proceeds to pay down debt.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407962\" data-linked=\"Breitburn Energy in 15M-unit public offering\" data-tweet=\"$BBEPQ - Breitburn Energy in 15M-unit public offering https://seekingalpha.com/news/1407962-breitburn-energy-in-15m-unit-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1407962-breitburn-energy-in-15m-unit-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407852\" data-ts=\"1384290824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407852-synta-pharmaceuticals-announces-offering-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synta Pharmaceuticals announces offering, shares fall</a></h4><ul>\n<li>Synta Pharmaceuticals (SNTA) commences a public offering.</li>\n<li>Jefferies is the book-runner. (PR)</li>\n<li>SNTA <font color=\"red\">-6%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407852\" data-linked=\"Synta Pharmaceuticals announces offering, shares fall\" data-tweet=\"$MDGL - Synta Pharmaceuticals announces offering, shares fall https://seekingalpha.com/news/1407852-synta-pharmaceuticals-announces-offering-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1407852-synta-pharmaceuticals-announces-offering-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407742\" data-ts=\"1384289975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDT\" target=\"_blank\">SDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407742-bad-day-for-the-sandridge-trusts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bad day for the SandRidge trusts</a></h4><ul>     <li>SandRidge Mississippian Trust I (<a href='https://seekingalpha.com/symbol/SDT' title='SandRidge Mississippian Trust I'>SDT</a> <font color='red'>-2.2%</font>) and Mississippian Trust II (<a href='https://seekingalpha.com/symbol/SDR' title='SandRidge Mississippian Trust II'>SDR</a> <font color='red'>-1.6%</font>) sink to new 52-week lows, and SandRidge Permian Trust (<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a> <font color='red'>-0.5%</font>) isn't far above similar lows.</li>     <li>Also lower: Chesapeake Granite Wash (<a href='https://seekingalpha.com/symbol/CHKR' title='Chesapeake Granite Wash Trust'>CHKR</a> <font color='red'>-3.9%</font>) and ECA&nbsp;Marcellus Trust (<a href='https://seekingalpha.com/symbol/ECT' title='ECA Marcellus Trust I'>ECT</a> <font color='red'>-3.6%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407742\" data-linked=\"Bad day for the SandRidge trusts\" data-tweet=\"$SDT $SDT $SDR - Bad day for the SandRidge trusts https://seekingalpha.com/news/1407742-bad-day-for-the-sandridge-trusts?source=tweet\" data-url=\"https://seekingalpha.com/news/1407742-bad-day-for-the-sandridge-trusts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407672\" data-ts=\"1384288930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHL\" target=\"_blank\">ATHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407672-athlon-energy-surges-on-strong-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Athlon Energy surges on strong Q3 results</a></h4><ul>     <li>Athlon Energy (<a href=\"https://seekingalpha.com/symbol/ATHL\" title=\"Athlon Energy Inc.\">ATHL</a> <font color=\"green\">+11.2%</font>) powers higher after posting <a href=\"https://seekingalpha.com/currents/post/1405192\" target=\"_blank\">Q3 earnings</a> and revenues that easily beat expectations.</li>     <li>Discretionary cash flow increased 93% to ~$54M in Q3 vs. ~$28M for the year-ago quarter.</li>     <li>Average daily production volumes rose  69% to 12,960 boe/day vs. 7,673 boe/day a year ago.</li>     <li>ATHL says it plans to provide FY 2014 outlook early in Q1, at which time it expects to provide initial production results on its first two horizontal Wolfcamp wells.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407672\" data-linked=\"Athlon Energy surges on strong Q3 results\" data-tweet=\"$ATHL - Athlon Energy surges on strong Q3 results https://seekingalpha.com/news/1407672-athlon-energy-surges-on-strong-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1407672-athlon-energy-surges-on-strong-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407662\" data-ts=\"1384288725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407662-baird-reportedly-cuts-amedisys-price-target-to-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird reportedly cuts Amedisys price target to $6</a></h4><ul>\n<li>Baird apparently doesn't like what it sees in Amedisys' (<a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"red\">-17.5%</font>) Q3 results. <br>\n</li>\n<li>According to <a href=\"https://twitter.com/thenotablecalls/status/400358763481165824\" target=\"_blank\">market chatter</a>, the firm has cut its price target on the shares to $6, representing downside of <strong><font color=\"red\">~58%</font></strong> <em>from current levels</em> (so that's 58% on top of the 17% it's down today).</li>\n<li>See also: AMED <a href=\"https://seekingalpha.com/currents/post/1406922\" target=\"_blank\">slides</a> on weak quarter, DOJ settlement</li>\n<li>CC <a href=\"https://seekingalpha.com/article/1832822-amedisys-management-discusses-q3-2013-results-earnings-call-transcript\" target=\"_blank\">transcript </a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407662\" data-linked=\"Baird reportedly cuts Amedisys price target to $6\" data-tweet=\"$AMED - Baird reportedly cuts Amedisys price target to $6 https://seekingalpha.com/news/1407662-baird-reportedly-cuts-amedisys-price-target-to-6?source=tweet\" data-url=\"https://seekingalpha.com/news/1407662-baird-reportedly-cuts-amedisys-price-target-to-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407632\" data-ts=\"1384287951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407632-financial-impact-of-baker-hughes-iraq-shutdown-uncertain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financial impact of Baker Hughes&#39; Iraq shutdown uncertain</a></h4><ul>     <li>It\u2019s <a href=\"http://fuelfix.com/blog/2013/11/12/financial-impact-of-baker-hughes-shutdown-in-iraq-uncertain/\" target=\"_blank\">too soon to quantify the financial impact</a> of the protest that <a href=\"https://seekingalpha.com/currents/post/1405792\" target=\"_blank\">shut down</a> Baker Hughes\u2019 (BHI <font color=\"red\">-2%</font>) operations in Iraq, but Tudor Pickering analysts note the company has a dozen rigs in the country which likely contributes 1%-2% of total revenue.</li>     <li>The firm says it expects lower margins in the region, but the incident  doesn\u2019t change its positive view of BHI stock; it just  highlights the \u201cever-present risks associated with southern Iraq.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407632\" data-linked=\"Financial impact of Baker Hughes&#39; Iraq shutdown uncertain\" data-tweet=\"$BHGE $BKR - Financial impact of Baker Hughes&#39; Iraq shutdown uncertain https://seekingalpha.com/news/1407632-financial-impact-of-baker-hughes-iraq-shutdown-uncertain?source=tweet\" data-url=\"https://seekingalpha.com/news/1407632-financial-impact-of-baker-hughes-iraq-shutdown-uncertain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407622\" data-ts=\"1384287369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCLN\" target=\"_blank\">SCLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407622-sciclone-pharmaceuticals-rises-zadaxin-sales-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SciClone Pharmaceuticals rises, Zadaxin sales in focus</a></h4><ul>\n<li>SciClone Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/SCLN\" title=\"SciClone Pharmaceuticals, Inc.\">SCLN</a> <font color=\"green\">+6.4%</font>) enjoys a decent session after reporting <a href=\"https://seekingalpha.com/currents/post/1404982\" target=\"_blank\">Q3 results</a>.</li>\n<li><em>Q3 <a href=\"https://seekingalpha.com/currents/search?query=zadaxin\" target=\"_blank\">Zadaxin</a> sales: $25M. That's +15% sequentially, but -20% Y/Y. CEO Friedhelm Blobel notes that while SCLN \"expects to see continued growth through the remainder of the  year, [the company] expects the rate of growth to continue to be affected by  external economic and industry factors.\" </em></li>\n<li>SCLN says it is pleased with \"negotiations  to restructure promotion partnerships with Baxter and Pfizer\" and notes that the agreement with Sanofi will expire at year end (this may affect Q4 revenue and EPS depending on how \"transition discussions\" turn out).</li>\n<li>FY13 revenue and EPS guidance confirmed (although at the low-end of the range): $0.55-0.61/share on sales of $135-145M. (PR)</li>\n<li>Aegis <a href=\"http://www.streetinsider.com/Analyst+Comments/Aegis+Capital+Cuts+PT+on+SciClone+%28SCLN%29+to+%248%3B+China+Restrictions+Will+Hamper+N-T+Results/8875511.html\" target=\"_blank\">cuts its price target</a> to $8 from $9 citing uncertainty regarding the operating environment in China. Analyst Raghuram Selvaraju sees the expiration of the Sanofi deal shaving $25M off annual revenue.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407622\" data-linked=\"SciClone Pharmaceuticals rises, Zadaxin sales in focus\" data-tweet=\"$SCLN - SciClone Pharmaceuticals rises, Zadaxin sales in focus https://seekingalpha.com/news/1407622-sciclone-pharmaceuticals-rises-zadaxin-sales-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1407622-sciclone-pharmaceuticals-rises-zadaxin-sales-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407612\" data-ts=\"1384287255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKP\" target=\"_blank\">CHKP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407612-check-point-higher-after-reaching-tax-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check Point higher after reaching tax deal</a></h4><ul>\n<li>Check Point (<a href=\"https://seekingalpha.com/symbol/CHKP\" title=\"Check Point Software Technologies Ltd.\">CHKP</a> <font color=\"green\">+2.8%</font>) has <a href=\"http://www.globes.co.il/serveen/globes/docview.asp?did=1000893219\" target=\"_blank\">struck a deal</a> with the Israeli government to pay NIS500M ($142M) in taxes on NIS1.7B ($482M) in profits that were deemed \"trapped\" (incapable of being distributed without a tax hit).</li>\n<li>Check Point had over $3.6B in cash/investments at the end of Q3, and no debt. The firewall vendor spent $128.3M of its cash on buybacks during the quarter.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407612\" data-linked=\"Check Point higher after reaching tax deal\" data-tweet=\"$CHKP - Check Point higher after reaching tax deal https://seekingalpha.com/news/1407612-check-point-higher-after-reaching-tax-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1407612-check-point-higher-after-reaching-tax-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407572\" data-ts=\"1384286427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSVC\" target=\"_blank\">GSVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407572-gsv-capital-lower-after-posting-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSV Capital lower after posting Q3 report</a></h4><ul>\n<li>GSV (<a href=\"https://seekingalpha.com/symbol/GSVC\" title=\"GSV Capital\">GSVC</a> <font color=\"red\">-5.4%</font>) saw a net change in unrealized asset appreciation of $8.9M, or $0.46/share in Q3. That compares with an increase of $12.2M ($0.63/share) in Q2.</li>\n<li>The firm, which currently has a market cap of $243.5M, ended Q3 with 46 portfolio investments worth an estimated $253M. GSV pegs the total value of its investments (inc. money market funds and owned/pledged investments) at $291.8M.</li>\n<li>Newly-public Twitter remained GSV's biggest investment; the firm estimates its Twitter stake was worth $44.8M (17.6% of NAV) at the end of Q3, up from $37.6M at the end of Q2. Stakes in Palantir Technologies, Dropbox, and Chegg (set to go public this week) respectively accounted for 10.3%, 5.9%, and 5.6% of NAV.</li>\n<li>A new investment was made in big data consulting services firm Strategic Data Command, and follow-on investments were made in five other startups.</li>\n<li>Shares are <font color=\"red\">down 18%</font> since last Wednesday's close; Twitter went public on Thursday morning.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407572\" data-linked=\"GSV Capital lower after posting Q3 report\" data-tweet=\"$GSVC $SSSS - GSV Capital lower after posting Q3 report https://seekingalpha.com/news/1407572-gsv-capital-lower-after-posting-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1407572-gsv-capital-lower-after-posting-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407512\" data-ts=\"1384285340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407512-deutsche-needham-talk-eteplirsen-as-sarepta-falls-by-nearly-two-thirds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche, Needham talk eteplirsen as Sarepta falls by nearly two-thirds</a></h4><ul>\n<li>Deutsche's Robyn Karnauskas <a href=\"http://www.streetinsider.com/Analyst+Comments/Sarepta+%28SRPT%29+Eteplirsen+Delay+Impacts+DCF+by+%2410sh+Each+Year+-+Deutsche+Bank/8873276.html\" target=\"_blank\">weighs in</a> on what, quite frankly, has been a <a href=\"https://seekingalpha.com/currents/post/1405802\" target=\"_blank\">nightmarish day</a> for Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-63.4%</font>).</li>\n<li>Karnauskas is now modeling a 2016 launch for <a href=\"https://seekingalpha.com/currents/search?query=eteplirsen\" target=\"_blank\">eteplirsen</a>. \"Every 1 year delay impacts the DCF by $10/share,\" the analyst notes.</li>\n<li>Needham's Chad Messer is also out with some commentary, saying that while he \"continues to believe in the efficacy and safety of eteplirsen, [he is] <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Downgrades+Sarepta+Therapeutic+%28SRPT%29+to+Hold/8874785.html\" target=\"_blank\">downgrading</a> [the] shares to Hold [after losing] visibility to the  regulatory hurdles for approval.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407512\" data-linked=\"Deutsche, Needham talk eteplirsen as Sarepta falls by nearly two-thirds\" data-tweet=\"$SRPT - Deutsche, Needham talk eteplirsen as Sarepta falls by nearly two-thirds https://seekingalpha.com/news/1407512-deutsche-needham-talk-eteplirsen-as-sarepta-falls-by-nearly-two-thirds?source=tweet\" data-url=\"https://seekingalpha.com/news/1407512-deutsche-needham-talk-eteplirsen-as-sarepta-falls-by-nearly-two-thirds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407502\" data-ts=\"1384285158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELLI\" target=\"_blank\">ELLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407502-ellie-mae-soars-on-report-of-p-e-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ellie Mae soars on report of P-E interest</a></h4><ul>\n<li>\n<a href=\"http://www.insidemortgagefinance.com/imfnews/1_227/daily/three-bidders-vying-for-ellie-mae-1000025120-1.html\" target=\"_blank\">IMF News</a> reports P-E firm Silver Lake (recently helped take Dell private) has considered buying Ellie Mae (<a href=\"https://seekingalpha.com/symbol/ELLI\" title=\"Ellie Mae, Inc.\">ELLI</a> <font color=\"green\">+11.7%</font>), and that the mortgage origination software vendor <a href=\"https://twitter.com/thenotablecalls/status/400342334866341888\" target=\"_blank\">has seen interest</a> from at least three different P-E firms.</li>\n<li>IMF also reports a sale could involve <a href=\"https://twitter.com/thenotablecalls/status/400345070680817664\" target=\"_blank\">a purchase price</a> in the $800M-$1.1B range. Ellie currently has a market cap of just $691M.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1258372\" target=\"_blank\">Reuters reported</a> in September Ellie had hired Morgan Stanley to help find a buyer. Shares tumbled two weeks ago after the company <a href=\"https://seekingalpha.com/currents/post/1376262\" target=\"_blank\">missed Q3 estimates </a>and issued <a href=\"https://seekingalpha.com/currents/post/1376862\" target=\"_blank\">soft Q4 guidance</a>, thanks in large part to declining mortgage application activity.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407502\" data-linked=\"Ellie Mae soars on report of P-E interest\" data-tweet=\"$ELLI - Ellie Mae soars on report of P-E interest https://seekingalpha.com/news/1407502-ellie-mae-soars-on-report-of-p-e-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/1407502-ellie-mae-soars-on-report-of-p-e-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407482\" data-ts=\"1384284575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407482-randgold-loses-luster-after-rbc-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Randgold loses luster after RBC downgrade</a></h4><ul>     <li>Randgold Resources (<a href=\"https://seekingalpha.com/symbol/GOLD\" title=\"Barrick Gold Corporation\">GOLD</a> <font color=\"red\">-3.8%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/RBC+Capital+Downgrades+Randgold+Resources+Ltd.+%28GOLD%29+to+Sector+Perform/8871423.html\" target=\"_blank\">downgraded</a> to Sector Perform from Outperform at RBC, based on valuation.</li>     <li>GOLD reported solid Q3 results and remains on track to hit 2013 guidance and bring Kibali into full production during 2014; the firm says the share price is relatively close to its unchanged target price of £54 following the recent rally.</li>\n<li>Also, GOLD <a href=\"http://www.benzinga.com/news/13/11/4070252/marriott-to-replace-rangold-resources-in-nasdaq-100-index-beginning-november-18-2\" target=\"_blank\">will be replaced</a> in the Nasdaq 100 index by Marriott (NYSE:<a href=\"https://seekingalpha.com/symbol/MAR\" title=\"Marriott International, Inc.\">MAR</a>) beginning next Monday.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407482\" data-linked=\"Randgold loses luster after RBC downgrade\" data-tweet=\"$GOLD $GOLD $MAR - Randgold loses luster after RBC downgrade https://seekingalpha.com/news/1407482-randgold-loses-luster-after-rbc-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1407482-randgold-loses-luster-after-rbc-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407462\" data-ts=\"1384284258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407462-achillion-rises-after-reiterating-pipeline-priorities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achillion rises after &quot;reiterating&quot; pipeline priorities</a></h4><ul>\n<li>Achillion Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACHN\" title=\"Achillion Pharmaceuticals, Inc.\">ACHN</a> <font color=\"green\">+6.8%</font>) gets a lift after \"reiterating\" its HCV pipeline priorities in its Q3 PR.</li>\n<li>Going forward, the company says it plans to \"to engage in regulatory discussions regarding the path forward for <a href=\"https://seekingalpha.com/currents/search?query=sovaprevir\" target=\"_blank\">sovaprevir</a>\" and initiate a \"drug-drug interaction study followed by a therapeutic trial\" for an ACH-3102/ ACH-2684 combo. For more on all of this, see ACHN's <a href=\"https://seekingalpha.com/currents/post/1303952\" target=\"_blank\">last pipeline update</a>.</li>\n<li>The company also notes that its current cash position ($173M) should be \"more than sufficient to reach several value creating milestones and fund operations for at least two years.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407462\" data-linked=\"Achillion rises after &quot;reiterating&quot; pipeline priorities\" data-tweet=\"$ACHN - Achillion rises after &quot;reiterating&quot; pipeline priorities https://seekingalpha.com/news/1407462-achillion-rises-after-reiterating-pipeline-priorities?source=tweet\" data-url=\"https://seekingalpha.com/news/1407462-achillion-rises-after-reiterating-pipeline-priorities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407432\" data-ts=\"1384283450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRCCQ\" target=\"_blank\">JRCCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407432-james-river-coal-falls-another-25-percent-as-bankruptcy-fears-mount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">James River Coal falls another 25% as bankruptcy fears mount</a></h4><ul>     <li>James River Coal (JRCC <font color=\"red\">-24.6%</font>) extends the slide begun last Thursday when it reported a <a href=\"https://seekingalpha.com/currents/post/1396482\" target=\"_blank\">worse than expected Q3 loss</a>, and concerns are growing that the company is sliding into bankruptcy.</li>     <li>JRCC's coal inventory levels are significantly higher than typical and appear to have reached an all-time high; drawing down its inventory would preserve liquidity until 2014, but a major rebound in the met coal market likely is necessary to avoid <a href=\"https://seekingalpha.com/article/1829712-james-river-coal-the-aftermath-of-q3-earnings-and-a-look-to-the-future\" target=\"_blank\">dangerously low liquidity levels</a> in H1 2014, according to Elephant Analytics.</li>\n<li>Other coal names also are lower: <a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"red\">-2.3%</font>, <a href=\"https://seekingalpha.com/symbol/BTU\" title=\"Peabody Energy Corp.\">BTU</a> <font color=\"red\">-3.7%</font>, <a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"red\">-4.6%</font>, ANR <font color=\"red\">-4%</font>, <a href=\"https://seekingalpha.com/symbol/WLT\" title=\"Walter Energy, Inc.\">WLT</a> <font color=\"red\">-7.8%</font>, <a href=\"https://seekingalpha.com/symbol/ACI\" title=\"Albertsons Companies Inc\">ACI</a> <font color=\"red\">-5.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407432\" data-linked=\"James River Coal falls another 25% as bankruptcy fears mount\" data-tweet=\"$JRCCQ $JRCCQ $CNX - James River Coal falls another 25% as bankruptcy fears mount https://seekingalpha.com/news/1407432-james-river-coal-falls-another-25-percent-as-bankruptcy-fears-mount?source=tweet\" data-url=\"https://seekingalpha.com/news/1407432-james-river-coal-falls-another-25-percent-as-bankruptcy-fears-mount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407422\" data-ts=\"1384282934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407422-galectin-updates-fatty-liver-disease-trial-reports-q3-results-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin updates fatty liver disease trial, reports Q3 results, shares fall</a></h4><ul>\n<li>Galectin Therapeutics (<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"red\">-10.7%</font>) drops after reporting Q3 results.</li>\n<li>The company says \"five of the eight patients have been enrolled and infused\" in a Phase 1 study of GR-MD-02 in NASH.</li>\n<li>Data from the first cohort of patients is due early next year assuming \"all goes as expected.\"</li>\n<li>As of September 30, GALT had $9.7M in cash which the company says should last \"into Q3 of 2014.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407422\" data-linked=\"Galectin updates fatty liver disease trial, reports Q3 results, shares fall\" data-tweet=\"$GALT - Galectin updates fatty liver disease trial, reports Q3 results, shares fall https://seekingalpha.com/news/1407422-galectin-updates-fatty-liver-disease-trial-reports-q3-results-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1407422-galectin-updates-fatty-liver-disease-trial-reports-q3-results-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407332\" data-ts=\"1384279984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407332-nq-mobile-higher-as-toro-investment-discloses-5-percent-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile higher as Toro Investment discloses 5% stake</a></h4><ul>\n<li>Ahead of this afternoon's Q3 report, Toro Investment Partners has disclosed a 5% stake in NQ (NQ <font color=\"green\">+3%</font>); at current levels, it's worth $105.8M. (<a href=\"http://www.sec.gov/Archives/edgar/data/1509986/000114420413060103/v360007_sc13g.htm\" target=\"_blank\">13G</a>)</li>\n<li>\n<a href=\"https://seekingalpha.com/author/toro-investment-partners/articles\" target=\"_blank\">Toro has written</a> several bullish SA columns on NQ this year. Yesterday, the firm provided <a href=\"https://seekingalpha.com/article/1829222-the-muddy-waters-nq-mobile-report-card\" target=\"_blank\">a lengthy column</a> detailing the NQ-related findings it has made during an ongoing Chinese trip, in an effort to counter Muddy Waters' fraud accusations.</li>\n<li>Among other things, Toro asserts MW provided a mistaken view of NQ partner Yidatong's financials by assuming its business tax is paid based on gross, rather than net, revenue, and that it found plenty of retailers selling NQ's prepaid cards.</li>\n<li>MW, meanwhile, has <a href=\"https://seekingalpha.com/article/1832032-nqs-u-s-veneer-withholding-facts-conned-men-and-a-convicted-racketeer\" target=\"_blank\">provided a column</a> questioning the background of Matt Mathison, NQ's Director of Capital Markets, highlighting the company's past ties with Anthony Sasso, who was once convicted of racketeering, and criticizing the lack of detail provided by co-CEO Omar Khan when asked about NQ's Chinese ops.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407332\" data-linked=\"NQ Mobile higher as Toro Investment discloses 5% stake\" data-tweet=\"$LKM - NQ Mobile higher as Toro Investment discloses 5% stake https://seekingalpha.com/news/1407332-nq-mobile-higher-as-toro-investment-discloses-5-percent-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1407332-nq-mobile-higher-as-toro-investment-discloses-5-percent-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407272\" data-ts=\"1384278815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNR\" target=\"_blank\">HNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407272-also-heard-during-harvest-naturals-earnings-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Also heard during Harvest Natural&#39;s earnings call</a></h4><ul>     <li>Heard during the Q&amp;A session of Harvest Natural's (<a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color='red'>-29.2%</font>) earnings call (<a href=\"https://seekingalpha.com/currents/post/1407212\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1407222\" target=\"_blank\">II</a>):</li>     <li>HNR says its cash burn rate is $2M/month; in the most recent quarter, it reported $4M cash on its balance sheet.</li>     <li>Says debt outstanding is due Oct. 2014, and quarterly interest runs ~$2.2M.</li>     <li>Asked about what can be done to raise capital, HNR says it can raise money through equity or bridge loans, and is looking at all options.</li></ul><div class=\"tiny-share-widget\" data-id=\"1407272\" data-linked=\"Also heard during Harvest Natural&#39;s earnings call\" data-tweet=\"$HNR - Also heard during Harvest Natural&#39;s earnings call https://seekingalpha.com/news/1407272-also-heard-during-harvest-naturals-earnings-call?source=tweet\" data-url=\"https://seekingalpha.com/news/1407272-also-heard-during-harvest-naturals-earnings-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407252\" data-ts=\"1384278354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407252-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"green\">+84%</font>. <a href=\"https://seekingalpha.com/symbol/OTIV\" title=\"On Track Innovations Ltd\">OTIV</a> <font color=\"green\">+28%</font>. <a href=\"https://seekingalpha.com/symbol/MPAA\" title=\"Motorcar Parts of America, Inc.\">MPAA</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/HTLD\" title=\"Heartland Express, Inc.\">HTLD</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/PERI\" title=\"Perion Network Ltd.\">PERI</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/HGSH\" title=\"China HGS Real Estate, Inc.\">HGSH</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/ALDW\" title=\"Alon USA Partners\">ALDW</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/CVR\" title=\"Chicago Rivet &amp; Machine Co\">CVR</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ESTE\" title=\"Earthstone Energy, Inc.\">ESTE</a> <font color=\"green\">+15%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-62%</font>. <a href=\"https://seekingalpha.com/symbol/DM\" title=\"Dominion Midstream Partners LP\">DM</a> <font color=\"red\">-50%</font>. <a href=\"https://seekingalpha.com/symbol/HNR\" title=\"Harvest Natural Resources, Inc.\">HNR</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/PTX\" title=\"Pernix Therapeutics Holdings, Inc.\">PTX</a> <font color=\"red\">-25%</font>. <a href=\"https://seekingalpha.com/symbol/LMIA\" title=\"LMI Aerospace, Inc.\">LMIA</a> <font color=\"red\">-20%</font>. <a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/BIOL\" title=\"Biolase, Inc.\">BIOL</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/DGLY\" title=\"Digital Ally, Inc.\">DGLY</a> <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407252\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$VNDA $OTIV $MPAA - Midday Gainers / Losers https://seekingalpha.com/news/1407252-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1407252-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407242\" data-ts=\"1384278234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407242-sony-expands-game-download-distribution-comfortable-with-ps4-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony expands game download distribution, comfortable with PS4 estimates</a></h4><ul>\n<li>In an effort to grow game distribution, Sony (<a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a> <font color=\"green\">+3.5%</font>) <a href=\"http://www.engadget.com/2013/11/12/sony-amazon-playstation-network-store/\" target=\"_blank\">has decided to allow</a> Amazon and other online retailers to sell digital PS3, PS4, and PS Vita titles. Amazon <a href=\"http://kotaku.com/welcome-to-the-amazon-playstation-network-store-1462747295\" target=\"_blank\">has already launched</a> a PlayStation Network Store, and is offering $5 in Network credit with certain game purchases.</li>\n<li>Separately, <a href=\"http://www.bloomberg.com/news/2013-11-11/sony-sees-sales-of-3-million-playstation-4-consoles-by-year-end.html\" target=\"_blank\">Sony says</a> it's comfortable with analyst forecasts for 3M PS4 sales by year's end. The company is also reiterating its target for 5M sales in FY14 (ends March '14). Sony's expectations for 2013 sales are noteworthy in light of the fact the PS4 won't launch in the company's home market of Japan <a href=\"http://www.theverge.com/2013/9/9/4709812/ps4-japan-release-date\" target=\"_blank\">until Feb. 22, 2014</a>.</li>\n<li>The PS4 launches on Friday, and the Xbox One a week later. Sony is counting on a lower price and a stronger focus on gamers - the One places a greater emphasis on acting as a living room entertainment hub - to give it an upper hand. Early <a href=\"https://seekingalpha.com/currents/post/1306752\" target=\"_blank\">gamer survey data</a> has been favorable.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407242\" data-linked=\"Sony expands game download distribution, comfortable with PS4 estimates\" data-tweet=\"$SNE - Sony expands game download distribution, comfortable with PS4 estimates https://seekingalpha.com/news/1407242-sony-expands-game-download-distribution-comfortable-with-ps4-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1407242-sony-expands-game-download-distribution-comfortable-with-ps4-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407222\" data-ts=\"1384277925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNR\" target=\"_blank\">HNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407222-harvest-natural-resources-plunges-after-liquidity-warning-asset-divestment-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvest Natural Resources plunges after liquidity warning, asset divestment plans</a></h4><ul><li>Harvest Natural Resources (<a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color='red'>-32.7%</font>) plunges after CEO Peter Hill says on the <a href=\"http://www.videonewswire.com/event.asp\" target=\"_blank\">conference call</a> that the company has received a \"default notice from our partner\" in Columbia, leading to $2.2M of losses. The company states it is working to reform the agreement.</li><li>Given difficulties of its Petro Delta assets and its \"significant competitive disadvantage given the exorbitant resulting cost of capital,\" the company is shopping its Gabonese and Venezuelan assets in pieces or in whole in order to return assets to shareholders.</li><li>Management notes grimly that the company's biggest near-term difficulty is its \"<a href=\"https://seekingalpha.com/currents/post/1407212\" target=\"_blank\">near-term liquidity</a>.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"1407222\" data-linked=\"Harvest Natural Resources plunges after liquidity warning, asset divestment plans\" data-tweet=\"$HNR - Harvest Natural Resources plunges after liquidity warning, asset divestment plans https://seekingalpha.com/news/1407222-harvest-natural-resources-plunges-after-liquidity-warning-asset-divestment-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/1407222-harvest-natural-resources-plunges-after-liquidity-warning-asset-divestment-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407212\" data-ts=\"1384277518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNR\" target=\"_blank\">HNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407212-harvest-naturals-biggest-challenge-is-near-term-liquidity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvest Natural&#39;s &quot;biggest challenge is near-term liquidity&quot;</a></h4><ul>     <li>From Harvest Natural's (<a href=\"https://seekingalpha.com/symbol/HNR\" title=\"Harvest Natural Resources, Inc.\">HNR</a> <font color=\"red\">-32.3%</font>) <a href=\"http://www.videonewswire.com/event.asp\" target=\"_blank\">earnings call</a> (begins ~12:30 into the call) \"Our biggest challenge is our near-term liquidity and its effect on our ability to negotiate the best terms, both in price and structure, for the sale of the company or the company's assets... The debt covenants around our debt due Oct. 2014 severely restrict our ability to bring on new debt... As the result of our late filing of the 2012 10-K, we no longer have an active S-3 shelf registration, which would have allowed our usage of our past ATM facility to meet our cash needs during this period.\" (<a href=\"https://seekingalpha.com/currents/post/1407112\" target=\"_blank\">earlier</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407212\" data-linked=\"Harvest Natural&#39;s &quot;biggest challenge is near-term liquidity&quot;\" data-tweet=\"$HNR - Harvest Natural&#39;s &quot;biggest challenge is near-term liquidity&quot; https://seekingalpha.com/news/1407212-harvest-naturals-biggest-challenge-is-near-term-liquidity?source=tweet\" data-url=\"https://seekingalpha.com/news/1407212-harvest-naturals-biggest-challenge-is-near-term-liquidity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407152\" data-ts=\"1384276889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407152-its-a-two-day-rally-for-sears-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s a two-day rally for Sears Holdings</a></h4><ul> <li>Shares of Sears Holdings (SHLD <font color=\"green\">+3%</font>) extend yesterday's gains to reach their highest levels of the month.</li> <li>Yesterday's announcement that Sears Canada will sell its interest in 8 properties has given traders something to chew on, while the high percentage of <a href=\"http://www.nasdaq.com/symbol/shld/short-interest\" target=\"_blank\">short interest</a> in the stock is still a factor during momentum swings.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1407152\" data-linked=\"It&#39;s a two-day rally for Sears Holdings\" data-tweet=\"$SHLDQ - It&#39;s a two-day rally for Sears Holdings https://seekingalpha.com/news/1407152-its-a-two-day-rally-for-sears-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/1407152-its-a-two-day-rally-for-sears-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407142\" data-ts=\"1384276833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407142-mens-wearhouse-spikes-on-activist-letter-that-ceo-is-considering-all-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Men&#39;s Wearhouse spikes on activist letter that CEO is considering all options</a></h4><ul><li>Men's Wearhouse (MW <font color='green'>+5.3%</font>) shares spike after 9.8% shareholder Eminence Capital <a href=\"http://www.financialjuice.com/News/396257/David-Faber-tweets-Latest-letter-from-Eminence-on-Mens-Wearhouse-MW-says-CEO-told-them-all-strategic-options-including-merger-with-Jos-Bank-JOSB-will-be-reviewed.aspx\" target=\"_blank\">writes</a> that CEO Douglas Ewert told the fund all strategic options are on the table, including the merger with Jos. A Bank (which has received&nbsp;on-again off-again speculation in the past month).</li></ul><div class=\"tiny-share-widget\" data-id=\"1407142\" data-linked=\"Men&#39;s Wearhouse spikes on activist letter that CEO is considering all options\" data-tweet=\"$TLRD - Men&#39;s Wearhouse spikes on activist letter that CEO is considering all options https://seekingalpha.com/news/1407142-mens-wearhouse-spikes-on-activist-letter-that-ceo-is-considering-all-options?source=tweet\" data-url=\"https://seekingalpha.com/news/1407142-mens-wearhouse-spikes-on-activist-letter-that-ceo-is-considering-all-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407112\" data-ts=\"1384276332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNR\" target=\"_blank\">HNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407112-harvest-natural-resources-abruptly-slides-by-more-than-20-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harvest Natural Resources abruptly slides by more than 20%</a></h4><ul><li>Harvest Natural Resources (<a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color='red'>-28.5%</font>)&nbsp;plunges suddenly just after the conclusion of its Q3 conference call.</li><li>Shares were paused briefly for volatility.</li></ul><div class=\"tiny-share-widget\" data-id=\"1407112\" data-linked=\"Harvest Natural Resources abruptly slides by more than 20%\" data-tweet=\"$HNR - Harvest Natural Resources abruptly slides by more than 20% https://seekingalpha.com/news/1407112-harvest-natural-resources-abruptly-slides-by-more-than-20-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1407112-harvest-natural-resources-abruptly-slides-by-more-than-20-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407102\" data-ts=\"1384276204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407102-amr-and-u-s-airways-settle-with-doj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMR and U.S. Airways settle with DOJ</a></h4><ul>\n<li>AMR (AAMRQ <font color=\"green\">+24%</font>) soars upon settlement of the DOJ suit over its merger with U.S. Airways (<a href=\"https://seekingalpha.com/symbol/LCC\" title=\"\">LCC</a> <font color=\"red\">-0.6%</font>).</li>\n<li>The two will divest 52 slot paris at Reagan National and 17 at LaGuardia, as well as two gates each at Logan International, O'Hare, Love Field, LAX, and Miami. Even with the divestitures, the new American is expected to generate net synergies of more than $1B beginning in 2015.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/IYT\" title=\"iShares Transportation Average ETF\">IYT</a> <font color=\"green\">+0.6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1407102\" data-linked=\"AMR and U.S. Airways settle with DOJ\" data-tweet=\"$AAL $AAL $IYT - AMR and U.S. Airways settle with DOJ https://seekingalpha.com/news/1407102-amr-and-u-s-airways-settle-with-doj?source=tweet\" data-url=\"https://seekingalpha.com/news/1407102-amr-and-u-s-airways-settle-with-doj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1407042\" data-ts=\"1384275413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WNR\" target=\"_blank\">WNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1407042-western-refining-deal-with-northern-tier-good-for-both-goldman-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Refining deal with Northern Tier good for both, Goldman says</a></h4><ul>     <li>Goldman Sachs says Western Refining's (<a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"green\">+7.2%</font>) move to <a href=\"https://seekingalpha.com/currents/post/1406582\" target=\"_blank\">acquire a 38.7% stake</a> in Northern Tier Energy (<a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a> <font color=\"green\">+1.1%</font>) is <a href=\"http://www.streetinsider.com/Analyst+Comments/Western+Refining+%28WNR%29+Northern+Tier+%28NTI%29+Deal+Good+For+Both+Companies%2C+Says+Goldman/8874256.html\" target=\"_blank\">good for both companies</a>, reiterating Buy ratings.</li>     <li>WNR gains access to NTI\u2019s St. Paul Park refinery, which has direct access to cost-advantaged Bakken and Canadian crude oils, the firm says.</li>     <li>For NTI, at a minimum the share overhang from its previous P-E owners is now eliminated; while awaiting more details on whether WNR plans to set up an MLP for its existing wholly-owned refineries, \"the potential certainly exists for NTI to benefit from greater asset  diversification while remaining a MidCon pure-play.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1407042\" data-linked=\"Western Refining deal with Northern Tier good for both, Goldman says\" data-tweet=\"$WNR $WNR $NTI - Western Refining deal with Northern Tier good for both, Goldman says https://seekingalpha.com/news/1407042-western-refining-deal-with-northern-tier-good-for-both-goldman-says?source=tweet\" data-url=\"https://seekingalpha.com/news/1407042-western-refining-deal-with-northern-tier-good-for-both-goldman-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406982\" data-ts=\"1384274542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406982-fedex-rallies-on-third-point-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx rallies on Third Point stake</a></h4><ul><li>Shares of FedEx (<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a> <font color='green'>+2.1%</font>)&nbsp;shake off a Cowen <a href=\"https://seekingalpha.com/currents/post/1405362\" target=\"_blank\">downgrade</a> to trade notably higher.</li><li>Helping the cause looks to be Dan Loeb, who <a href=\"http://blogs.wsj.com/moneybeat/2013/11/12/dan-loeb-has-taken-stake-in-fedex-met-with-ceo-fred-smith/\" target=\"_blank\">disclosed a position</a> in the company and made some positive comments about CEO Fred Smith in an interview with Andrew Ross Sorkin today.</li></ul><div class=\"tiny-share-widget\" data-id=\"1406982\" data-linked=\"FedEx rallies on Third Point stake\" data-tweet=\"$FDX - FedEx rallies on Third Point stake https://seekingalpha.com/news/1406982-fedex-rallies-on-third-point-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1406982-fedex-rallies-on-third-point-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406972\" data-ts=\"1384274282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTLD\" target=\"_blank\">HTLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406972-heartland-express-buys-trucking-peer-in-300m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heartland Express buys trucking peer in $300M deal</a></h4><ul>     <li>Heartland Express (<a href=\"https://seekingalpha.com/symbol/HTLD\" title=\"Heartland Express, Inc.\">HTLD</a> <font color=\"green\">+18.8%</font>) agrees to acquire privately-held peer Gordon Trucking in a deal valued at ~$300M, creating a trucking firm with ~$1B in combined annual revenue and a terminal network spanning across much of the U.S.</li>     <li>HTLD says the deal will immediately add to earnings, excluding transaction-related expenses, and turn it into the fifth-largest asset-based truckload fleet in North America.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406972\" data-linked=\"Heartland Express buys trucking peer in $300M deal\" data-tweet=\"$HTLD - Heartland Express buys trucking peer in $300M deal https://seekingalpha.com/news/1406972-heartland-express-buys-trucking-peer-in-300m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1406972-heartland-express-buys-trucking-peer-in-300m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406962\" data-ts=\"1384273891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTX\" target=\"_blank\">PTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406962-pernix-therapeutics-lowers-full-year-revenue-guidance-shares-dive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pernix Therapeutics lowers full-year revenue guidance, shares dive</a></h4><ul>\n<li>Pernix Therapeutics (<a href=\"https://seekingalpha.com/symbol/PTX\" title=\"Pernix Therapeutics Holdings, Inc.\">PTX</a> <font color=\"red\">-24.6%</font>) plunges after reporting Q3 results, erasing big gains posted on Friday.</li>\n<li>Revenue for the period ticked higher by 1%, although sales of the company's legacy products fell during Q3.</li>\n<li>The Cypress Hawthorn acquisition makes SG&amp;A a tough compare over Q3 2012.</li>\n<li>PTX says it has \"implemented net personnel reductions which will       generate additional annualized savings of approximately $2M.\"</li>\n<li>\n<em>FY13 outlook: Revenue of $80M versus previous guidance of $90-100M.</em> (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406962\" data-linked=\"Pernix Therapeutics lowers full-year revenue guidance, shares dive\" data-tweet=\"$PTX $PTX-OLD - Pernix Therapeutics lowers full-year revenue guidance, shares dive https://seekingalpha.com/news/1406962-pernix-therapeutics-lowers-full-year-revenue-guidance-shares-dive?source=tweet\" data-url=\"https://seekingalpha.com/news/1406962-pernix-therapeutics-lowers-full-year-revenue-guidance-shares-dive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406922\" data-ts=\"1384273042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMED\" target=\"_blank\">AMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406922-amedisys-falls-as-weak-quarter-hits-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amedisys falls as weak quarter hits full-year guidance</a></h4><ul>\n<li>Amedisys (<a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"red\">-13.5%</font>) books a $150M accrual in Q3 for its tentative deal with the U.S. DOJ. The settlement was struck without admission of wrongdoing.</li>\n<li> $145M was added back to get to the company's adjusted results for the period, but even so, CEO William Borne characterizes the results as \"below       expectations.\" Borne blames \"soft       volume in both [the] home health and hospice business units and higher       costs.\"</li>\n<li>FY13 outlook (this is adjusted to exclude the DOJ accrual): EPS of $0.20-0.25 (versus previous guidance of $0.45-0.55) on revenue of $1.24-1.25B (versus previous guidance of $1.24-1.28B). Consensus is $0.55/share on revenue of $1.28B. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406922\" data-linked=\"Amedisys falls as weak quarter hits full-year guidance\" data-tweet=\"$AMED - Amedisys falls as weak quarter hits full-year guidance https://seekingalpha.com/news/1406922-amedisys-falls-as-weak-quarter-hits-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1406922-amedisys-falls-as-weak-quarter-hits-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406892\" data-ts=\"1384272467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406892-yelp-rallies-following-jefferies-pt-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp rallies following Jefferies PT hike</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Yelp+%28YELP%29+PT+Lifted+to+%2480+at+Jefferies/8871740.html\" target=\"_blank\">Jefferies</a> has raised its Yelp (<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a> <font color=\"green\">+3.5%</font>) PT to $80 from $50. The firm asserts Yelp's \"breadth, depth and penetration of content is very hard to replicate,\" and remains the company's \"core competitive advantage.\"</li>\n<li>Concerns about intensified competition from <a href=\"https://seekingalpha.com/currents/post/763041\" target=\"_blank\">Facebook</a> and <a href=\"https://seekingalpha.com/currents/post/718531\" target=\"_blank\">Google</a> has pressured Yelp's shares more than once. But as the company's Q3 metrics demonstrate - cumulative reviews, monthly visitors, and active local business accounts respectively rose 42%, 41%, and 61% Y/Y - it hasn't done much damage yet to Yelp's local reviews dominance.</li>\n<li>Like many other Internet names, Yelp has sold off a bit from its October highs. But shares remain <strong><font color=\"green\">up 246%</font></strong> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406892\" data-linked=\"Yelp rallies following Jefferies PT hike\" data-tweet=\"$YELP - Yelp rallies following Jefferies PT hike https://seekingalpha.com/news/1406892-yelp-rallies-following-jefferies-pt-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/1406892-yelp-rallies-following-jefferies-pt-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406872\" data-ts=\"1384272214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOLX\" target=\"_blank\">HOLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406872-hologic-shares-hit-hard-as-goodwill-charge-guidance-weigh-heavily\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hologic shares hit hard as goodwill charge, guidance weigh heavily</a></h4><ul>\n<li>Hologic (<a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a> <font color=\"red\">-14.2%</font>) slides after reporting FQ4 results.</li>\n<li>Although the company reported adjusted net income of $0.39/share, it put up a GAAP loss of $1.1B or $4.11/share thanks to a goodwill impairment charge of $1.1B.</li>\n<li>HOLX notes that it \"has significant goodwill on its balance sheet as a result of its acquisitions\" and during an annual review, it determined that \"that a portion of its goodwill within its Diagnostics business segment was impaired.\" The diagnostics business had revenues of $290M for Q4, $147.9M of which came from Gen-Probe, which was <a href=\"https://seekingalpha.com/currents/post/281621\" target=\"_blank\">acquired</a> last year in a $3.7B deal.</li>\n<li>Revenue growth/contraction in other segments: Breast Health, +1.7%; GYN Surgical, -3.8%; Skeletal Health, -15.3%.</li>\n<li>The company announces a $250M buyback authorization.</li>\n<li>FQ1 guidance: Adjusted EPS of $0.30-0.31 on revenue of $600-610M \u2014 that's down 5-7% Y/Y and well below consensus of $0.40/share on sales of $642.4M.</li>\n<li>FY14 guidance: Adjusted EPS of $1.32-1.38 on revenue of $2.425-2.475B. Consensus is $1.63/share on sales of $2.59B. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406872\" data-linked=\"Hologic shares hit hard as goodwill charge, guidance weigh heavily\" data-tweet=\"$HOLX - Hologic shares hit hard as goodwill charge, guidance weigh heavily https://seekingalpha.com/news/1406872-hologic-shares-hit-hard-as-goodwill-charge-guidance-weigh-heavily?source=tweet\" data-url=\"https://seekingalpha.com/news/1406872-hologic-shares-hit-hard-as-goodwill-charge-guidance-weigh-heavily\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406822\" data-ts=\"1384271331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENLK\" target=\"_blank\">ENLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406822-crosstex-energy-lp-enjoys-two-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crosstex Energy LP enjoys two upgrades</a></h4><ul>     <li>Crosstex Energy LP (XTEX <font color=\"green\">+4.2%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/11/4072463/update-rbc-capital-markets-upgrades-crosstex-energy-on-p\" target=\"_blank\">upgraded</a> to Outperform from Sector Perform with a $29 target price at RBC, which says the combination with Devon Midstream should result in a lower-risk investment-grade MLP, with attractive sponsor support offering increasing organic and dropdown growth options.</li>     <li>Within this context, the firm thinks the 5.6% yield and above-average distribution growth outlook  screens attractively vs. other investment-grade MLPs; execution on new projects is a key risk, but management has proven itself through a diverse project slate this year.</li>\n<li>Baird also <a href=\"http://www.streetinsider.com/Upgrades/Baird+Upgrades+Crosstex+Energy+%28XTEX%29+to+Outperform/8871640.html\" target=\"_blank\">upgrades</a> XTEX to Outperform, adding that Crosstex Energy Inc. (XTXI) appears fully valued following the Devon announcement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406822\" data-linked=\"Crosstex Energy LP enjoys two upgrades\" data-tweet=\"$ENLK $ENLK $DVN - Crosstex Energy LP enjoys two upgrades https://seekingalpha.com/news/1406822-crosstex-energy-lp-enjoys-two-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1406822-crosstex-energy-lp-enjoys-two-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406802\" data-ts=\"1384271118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406802-vringo-higher-after-providing-zte-german-trial-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vringo higher after providing ZTE German trial update</a></h4><ul>\n<li>Vringo (VRNG <font color=\"green\">+4.9%</font>) states a German court will rule on an infringement claim levied by the company against ZTE on Dec. 17 at 9:00AM local time. Vringo asserts ZTE's 3G infrastructure equipment is infringing one of its European patents. (PR)</li>\n<li>Vringo is also suing ZTE in the U.K., France, Australia, and Spain, and asserting a second patent against ZTE in Germany. A hearing related to the second patent is set for 1H14, and the first trial for Vringo's U.K. battle (the company has filed two U.K. suits against ZTE) is set for 2H14.</li>\n<li><a href=\"https://seekingalpha.com/currents/search?query=vrng%20zte\" target=\"_blank\">More on Vringo/ZTE</a></li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1390312\" target=\"_blank\">Previous:</a> USPTO affirms validity of Vringo patent</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406802\" data-linked=\"Vringo higher after providing ZTE German trial update\" data-tweet=\"$XSPA - Vringo higher after providing ZTE German trial update https://seekingalpha.com/news/1406802-vringo-higher-after-providing-zte-german-trial-update?source=tweet\" data-url=\"https://seekingalpha.com/news/1406802-vringo-higher-after-providing-zte-german-trial-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406762\" data-ts=\"1384270267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NS\" target=\"_blank\">NS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406762-nustar-energy-foresees-improved-q4-and-2014-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuStar Energy foresees improved Q4 and 2014 results</a></h4><ul>     <li>NuStar Energy (<a href='https://seekingalpha.com/symbol/NS' title='NuStar Energy L.P.'>NS</a> <font color='green'>+5.5%</font>) reported <a href=\"https://seekingalpha.com/currents/post/1406352\" target=\"_blank\">Q3 earnings</a> and revenue below analyst expectations, but an upbeat outlook is sending shares higher.</li>     <li>Q4 EBITDA for all three NS segments should  be higher than last year&rsquo;s Q4, the company says, adding that its pipeline segment EBITDA should be $60M-$70M higher than last year.</li>     <li>Looking ahead to 2014, increased crude oil throughputs in the Eagle Ford region should increase the pipeline segment's EBITDA by an additional $40M-$60M; NS says it expect to fully cover its distribution in 2014.</li><li>Says it is in advanced talks with asphalt joint venture partner Lindsay Goldberg to exit its stake, which NS says would allow it to materially reduce its $250M credit facility and $150M of credit support.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406762\" data-linked=\"NuStar Energy foresees improved Q4 and 2014 results\" data-tweet=\"$NS - NuStar Energy foresees improved Q4 and 2014 results https://seekingalpha.com/news/1406762-nustar-energy-foresees-improved-q4-and-2014-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1406762-nustar-energy-foresees-improved-q4-and-2014-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406742\" data-ts=\"1384270064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406742-microvision-makes-new-52-week-lows-after-releasing-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision makes new 52-week lows after releasing Q3 results</a></h4><ul>\n<li>MicroVision's (<a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a> <font color=\"red\">-9.3%</font>) Q3 sales fell 48% Q/Q and 63% Y/Y to a mere $964K. Revenue \"primarily\" stemmed from <a href=\"https://seekingalpha.com/currents/post/923051\" target=\"_blank\">an April deal</a> with a \"prominent electronics company.\" The miniature laser projector tech developer says it's \"engaged in commercial negotiations for licensing and component supply agreements\" with said company.</li>\n<li>Product revenue totaled $176K, contract revenue $128K, and development revenue $660K. MicroVision's cash balance rose by $2.3M Q/Q to $8.3M. Backlog fell by $600K to $3.2M.</li>\n<li>Opex was $5M, up from Q2's $4.4M but down from $5.5M a year ago.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1406182\" target=\"_blank\">Q3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406742\" data-linked=\"MicroVision makes new 52-week lows after releasing Q3 results\" data-tweet=\"$MVIS - MicroVision makes new 52-week lows after releasing Q3 results https://seekingalpha.com/news/1406742-microvision-makes-new-52-week-lows-after-releasing-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1406742-microvision-makes-new-52-week-lows-after-releasing-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406692\" data-ts=\"1384268807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PERI\" target=\"_blank\">PERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406692-perion-network-jumps-on-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perion Network jumps on Q3 results</a></h4><ul>\n<li>Shares of Perion Network (<a href=\"https://seekingalpha.com/symbol/PERI\" title=\"Perion Network Ltd.\">PERI</a> <font color=\"green\">+18.8%</font>) jump after the company beat expectations <a href=\"https://seekingalpha.com/currents/post/1405342\" target=\"_blank\">in Q3</a>.</li>\n<li>Revenue grew 31% Y/Y to $21.3M, driven by a 25% Y/Y increase in search generated revenue and a 43% increase in other revenue.</li>\n<li>Management guides for full-year revenue of $102M-$104M (vs. consensus of $105.6M), EBITDA of $24M-$25M, and EPS of $1.38-$1.45 ($1.37).</li>\n<li>Shares are recovering after having <font color=\"red\">tanked 19% </font> since fellow toolbar provider Babylon <a href=\"https://seekingalpha.com/currents/post/1369852\" target=\"_blank\">lost</a> its deal with Google at the end of Oct. Perion noted that no one search provider is responsible for more than 40% of revenue.</li>\n<li>PR, <a href=\"http://public.viavid.com/player/index.php?id=106673\" target=\"_blank\">Conference call</a> at 10 am ET</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406692\" data-linked=\"Perion Network jumps on Q3 results\" data-tweet=\"$PERI - Perion Network jumps on Q3 results https://seekingalpha.com/news/1406692-perion-network-jumps-on-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1406692-perion-network-jumps-on-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406682\" data-ts=\"1384268800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406682-symantec-lower-after-products-services-chief-leaves-macquarie-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Symantec lower after products/services chief leaves, Macquarie downgrades</a></h4><ul>\n<li>Francis deSouza, Symantec's (<a href=\"https://seekingalpha.com/symbol/SYMC\" title=\"Symantec Corporation\">SYMC</a> <font color=\"red\">-3.7%</font>) president of products/services and a 7-year company vet, is leaving to become the president of DNA analysis hardware vendor Illumina. Symantec's products/services management team will now report directly to CEO Steve Bennett. (PR)</li>\n<li>deSouza's departure comes six weeks after <a href=\"https://seekingalpha.com/currents/post/1303252\" target=\"_blank\">EMC announced</a> it has hired Symantec storage management software chief C.J. Desai to run its new Emerging Technology Products unit. It also comes three weeks after Symantec's shares tumbled due to a <a href=\"https://seekingalpha.com/currents/post/1349022\" target=\"_blank\">revenue miss</a> and soft guidance; the company reported <a href=\"https://seekingalpha.com/currents/post/1349582\" target=\"_blank\">Y/Y sales declines</a> for all three of its major product segments (PC/mobile security, enterprise security, and storage software).</li>\n<li>Macquarie has cut Symantec to Neutral; the firm cites executive departures as one of its reasons. <a href=\"http://www.marketwatch.com/story/symantec-shares-falls-top-exec-departing-2013-11-12\" target=\"_blank\">JPMorgan:</a> \"We view Mr. deSouza as a strong technology leader who will be missed at Symantec.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406682\" data-linked=\"Symantec lower after products/services chief leaves, Macquarie downgrades\" data-tweet=\"$SYMC $NLOK - Symantec lower after products/services chief leaves, Macquarie downgrades https://seekingalpha.com/news/1406682-symantec-lower-after-products-services-chief-leaves-macquarie-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/1406682-symantec-lower-after-products-services-chief-leaves-macquarie-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406632\" data-ts=\"1384268343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DF\" target=\"_blank\">DF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406632-food-sector-rattled-a-bit-by-report-from-dean-foods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Food sector rattled a bit by report from Dean Foods</a></h4><ul> <li>Margin worries at Dean Foods (<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a> <font color='red'>-7.6%</font>)&nbsp;is affecting sentiment over a number of other packaged foods companies in early trading.</li> <li>Though the company <a href=\"https://seekingalpha.com/currents/post/140644\" target=\"_blank\">warned</a> specifically on the dairy commodity environment, its drop in guidance on Q4 \"challenges\" looks a bit broader.</li> <li>Underperformers: KRFT <font color='red'>-0.7%</font>, <a href='https://seekingalpha.com/symbol/SJM' title='J. M. Smucker Company'>SJM</a> <font color='red'>-1.0%</font>, <a href='https://seekingalpha.com/symbol/HAIN' title='The Hain Celestial Group, Inc.'>HAIN</a> <font color='red'>-1.0%</font>, <a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a> <font color='red'>-0.5%</font>, <a href='https://seekingalpha.com/symbol/CPB' title='Campbell Soup Company'>CPB</a> <font color='red'>-1.0%</font>, <a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='red'>-0.6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1406632\" data-linked=\"Food sector rattled a bit by report from Dean Foods\" data-tweet=\"$DF $DF $KHC - Food sector rattled a bit by report from Dean Foods https://seekingalpha.com/news/1406632-food-sector-rattled-a-bit-by-report-from-dean-foods?source=tweet\" data-url=\"https://seekingalpha.com/news/1406632-food-sector-rattled-a-bit-by-report-from-dean-foods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406592\" data-ts=\"1384267497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VJET\" target=\"_blank\">VJET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406592-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>Voxeljet (<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='red'>-3.5%</font>) has received one bullish rating and two neutral ones on underwriter coverage day.</li><li>Veeco (<a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a> <font color='red'>-3.6%</font>) has been cut to Sell by Noble Financial, and started at Sell by Canaccord. The company delivered <a href=\"https://seekingalpha.com/currents/post/1399862\" target=\"_blank\">mixed Q3 results</a> last Friday.</li><li>Rovi (<a href='https://seekingalpha.com/symbol/ROVI' title='Rovi Corporation'>ROVI</a> <font color='green'>+4.1%</font>) has been upgraded to Sector Perform by Pac Crest. The upgrade comes as <a href=\"http://finance.yahoo.com/news/rovi-signs-panasonic-soc-first-133000426.html\" target=\"_blank\">Rovi announces</a> a DivX video codec licensing deal with Panasonic. Goldman cut shares to Sell last week, following the company's <a href=\"https://seekingalpha.com/currents/post/1370952\" target=\"_blank\">Q3 miss</a>.</li><li>Gogo (<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+2.2%</font>) has been cut to Neutral by UBS after flying higher yesterday thanks to a <a href=\"https://seekingalpha.com/currents/post/1402552\" target=\"_blank\">Q3 beat</a> and strong <a href=\"https://seekingalpha.com/currents/post/1403062\" target=\"_blank\">Q4 guidance</a>.</li><li>Faro (<a href='https://seekingalpha.com/symbol/FARO' title='FARO Technologies, Inc.'>FARO</a> <font color='red'>-2%</font>) has been cut to Hold by Stifel. Shares closed yesterday near their 52-week high, after surging two weeks ago in response to a <a href=\"https://seekingalpha.com/currents/post/1371632\" target=\"_blank\">Q3 beat</a>.</li><li>Cyan (CYNI <font color='green'>+4.2%</font>) has been started at Market Perform by FBR.  With shares having closed near their post-IPO lows yesterday, investors  seem pleased.</li></ul><div class=\"tiny-share-widget\" data-id=\"1406592\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$VJET $VJET $VECO - A roundup of tech ratings changes https://seekingalpha.com/news/1406592-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1406592-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406582\" data-ts=\"1384267257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTI\" target=\"_blank\">NTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406582-western-refining-confirms-deal-to-own-38_7-percent-of-northern-tier-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Refining confirms deal to own 38.7% of Northern Tier Energy</a></h4><ul>     <li>Northern Tier Energy (<a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a> <font color=\"green\">+3.5%</font>) confirms that its private equity sponsors have agreed to sell all of their  interests in NTI, including those of the general  partner, to Western Refining (<a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"green\">+9.3%</font>) for $775M; WNR now owns 100% of the general partner and 38.7% of NTI. (<a href=\"https://seekingalpha.com/currents/post/1404782\" target=\"_blank\">earlier</a>)</li>     <li>WNR says the deal adds scale to its business and diversifies operations by adding a new geographic region to its refining platform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406582\" data-linked=\"Western Refining confirms deal to own 38.7% of Northern Tier Energy\" data-tweet=\"$NTI $NTI $WNR - Western Refining confirms deal to own 38.7% of Northern Tier Energy https://seekingalpha.com/news/1406582-western-refining-confirms-deal-to-own-38_7-percent-of-northern-tier-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/1406582-western-refining-confirms-deal-to-own-38_7-percent-of-northern-tier-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406442\" data-ts=\"1384266417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DF\" target=\"_blank\">DF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406442-dean-foods-lower-after-soft-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dean Foods lower after soft profit guidance</a></h4><ul> <li>Dean Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/DF\" title=\"Dean Foods Company\">DF</a>) lowers it forecast for FY13 EPS to $0.85-$0.91 vs. prior guidance of $0.94-$1.06.</li> <li>While margins were squeezed on the costs side during <a href=\"https://seekingalpha.com/currents/post/1405812\" target=\"_blank\">Q3</a>, the company also saw its share of the U.S. fluid milk sales volume fell 150 bps to 34.9% during the period.</li> <li>DF <font color=\"red\">-3.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406442\" data-linked=\"Dean Foods lower after soft profit guidance\" data-tweet=\"$DF - Dean Foods lower after soft profit guidance https://seekingalpha.com/news/1406442-dean-foods-lower-after-soft-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1406442-dean-foods-lower-after-soft-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406392\" data-ts=\"1384266175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTS\" target=\"_blank\">APTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406392-preferred-apartments-upsizes-and-prices-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Preferred Apartments upsizes and prices secondary</a></h4><ul><li>Preferred Apartment Communities (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/APTS\" title=\"Preferred Apartment Communities\">APTS</a>) <font color=\"red\">falls 7.2%</font> to $7.62 after pricing its secondary offering at $7.75 each. The size of the offering was boosted 20% to 3.87M shares. The greenshoe option for the underwriters is about 580K shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"1406392\" data-linked=\"Preferred Apartments upsizes and prices secondary\" data-tweet=\"$APTS - Preferred Apartments upsizes and prices secondary https://seekingalpha.com/news/1406392-preferred-apartments-upsizes-and-prices-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/1406392-preferred-apartments-upsizes-and-prices-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406372\" data-ts=\"1384266062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUIK\" target=\"_blank\">QUIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406372-quicklogic-prices-stock-offering-shares-minus-12-percent-premarket-to-2_90\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuickLogic prices stock offering, shares -12% premarket to $2.90</a></h4><ul>\n<li>QuickLogic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QUIK\" title=\"QuickLogic Corporation\">QUIK</a>) is selling 7.6M shares at $2.90, and giving underwriters a 1.14M-share overallotment option. The chipmaker expects net proceeds of $20.6M. (PR)</li>\n<li>Assuming the overallotment option isn't used, the offering stands to increase QuickLogic's diluted share count by 17%.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1404152\" target=\"_blank\">Previous:</a> QuickLogic announces stock offering, doesn't disclose size</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406372\" data-linked=\"QuickLogic prices stock offering, shares -12% premarket to $2.90\" data-tweet=\"$QUIK - QuickLogic prices stock offering, shares -12% premarket to $2.90 https://seekingalpha.com/news/1406372-quicklogic-prices-stock-offering-shares-minus-12-percent-premarket-to-2_90?source=tweet\" data-url=\"https://seekingalpha.com/news/1406372-quicklogic-prices-stock-offering-shares-minus-12-percent-premarket-to-2_90\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406322\" data-ts=\"1384265735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406322-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>\n<li> <b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"green\">+79%</font>. <a href=\"https://seekingalpha.com/symbol/ARTX\" title=\"Arotech Corporation\">ARTX</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/PERI\" title=\"Perion Network Ltd.\">PERI</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a> <font color=\"green\">+11%</font>. NQ <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/MPAA\" title=\"Motorcar Parts of America, Inc.\">MPAA</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/SLTM\" title=\"Solta Medical, Inc\">SLTM</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CIMT\" title=\"Cimatron, Limited\">CIMT</a> <font color=\"green\">+7%</font>.  <a href=\"https://seekingalpha.com/symbol/UNIS\" title=\"Unilife Corporation\">UNIS</a> <font color=\"green\">+6%</font>.  <a href=\"https://seekingalpha.com/symbol/ELX\" title=\"Emulex Corporation\">ELX</a> <font color=\"green\">+6%</font>.  <a href=\"https://seekingalpha.com/symbol/AGO\" title=\"Assured Guaranty Ltd.\">AGO</a> <font color=\"green\">+6%</font>.  <a href=\"https://seekingalpha.com/symbol/EJ\" title=\"E-House (China) Holdings Limited\">EJ</a> <font color=\"green\">+6%</font>. </li>\n<li> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-54%</font>. HSOL <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/QUIK\" title=\"QuickLogic Corporation\">QUIK</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"red\">-6%</font>. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406322\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$VNDA $ARTX $PERI - Premarket Gainers / Losers https://seekingalpha.com/news/1406322-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1406322-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406312\" data-ts=\"1384265682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNA\" target=\"_blank\">RNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406312-prosensa-rises-as-sell-side-begins-to-digest-fda-stance-on-sareptas-eteplirsen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prosensa rises as sell-side begins to digest FDA stance on Sarepta&#39;s eteplirsen</a></h4><ul>\n<li>Prosensa (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a>) rallies <font color=\"green\">11% </font>in premarket trading.</li>\n<li>The shares are likely responding to news that the FDA currently considers an NDA for Sarepta's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) <a href=\"https://seekingalpha.com/currents/search?query=eteplirsen\" target=\"_blank\">eteplirsen</a> to be premature.</li>\n<li>Worth noting: The FDA's <a href=\"https://seekingalpha.com/currents/post/1405802\" target=\"_blank\">commentary</a> on <a href=\"https://seekingalpha.com/currents/search?query=drisapersen\" target=\"_blank\">drisapersen</a> wasn't exactly upbeat, but bad news for SRPT is considered good news for RNA as the companies are developing potentially competing DMD treatments.</li>\n<li>The sell-side is beginning to weigh in on the eteplirsen news. Citi reportedly thinks SRPT <a href=\"https://twitter.com/thenotablecalls/status/400250783750291457\" target=\"_blank\">could trade between</a> $10-20 on the news (a pretty good bet considering it's already trading below $20 before the bell) as the company attempts to devise suitable endpoints, while Canaccord <a href=\"https://twitter.com/thenotablecalls/status/400251921639821312\" target=\"_blank\">flags</a> heightened regulatory and clinical risk.</li>\n<li>SRPT now<strong> <font color=\"red\">-54%</font></strong>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406312\" data-linked=\"Prosensa rises as sell-side begins to digest FDA stance on Sarepta&#39;s eteplirsen\" data-tweet=\"$RNA $RNA $SRPT - Prosensa rises as sell-side begins to digest FDA stance on Sarepta&#39;s eteplirsen https://seekingalpha.com/news/1406312-prosensa-rises-as-sell-side-begins-to-digest-fda-stance-on-sareptas-eteplirsen?source=tweet\" data-url=\"https://seekingalpha.com/news/1406312-prosensa-rises-as-sell-side-begins-to-digest-fda-stance-on-sareptas-eteplirsen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406202\" data-ts=\"1384264749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406202-solar-stocks-down-premarket-following-yingli-and-hanwhas-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar stocks down premarket following Yingli and Hanwha&#39;s results</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1403992\" target=\"_blank\">Up strongly yesterday</a>, ever-volatile solar stocks are giving back some of their gains in premarket trading today after Yingli (<a href=\"https://seekingalpha.com/currents/post/1405522\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1405752\" target=\"_blank\">II</a>) and Hanwha (<a href=\"https://seekingalpha.com/currents/post/1405012\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1405922\" target=\"_blank\">II</a>) provided Q3 results and full-year guidance that left investors wanting more following big 2013 run-ups.</li>     <li>Notable decliners: <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-3.9%</font>. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"red\">-5.2%</font>. <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-3.4%</font>. <a href=\"https://seekingalpha.com/symbol/CSUN\" title=\"China Sunergy Co., Ltd.\">CSUN</a> <font color=\"red\">-3.3%</font>. SCTY <font color=\"red\">-1.3%</font>. SUNE <font color=\"red\">-2.5%</font>.</li>     <li>Also: Canadian Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a>) is <font color=\"red\">down 2.4%</font> in spite of announcing a 32MW module supply deal for a Chinese solar plant, and First Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a>) is <font color=\"red\">down 0.7%</font> in spite of announcing it has obtained power purchase agreements for a 40MW California power plant it's building.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406202\" data-linked=\"Solar stocks down premarket following Yingli and Hanwha&#39;s results\" data-tweet=\"$TSL $TSL $JKS - Solar stocks down premarket following Yingli and Hanwha&#39;s results https://seekingalpha.com/news/1406202-solar-stocks-down-premarket-following-yingli-and-hanwhas-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1406202-solar-stocks-down-premarket-following-yingli-and-hanwhas-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406092\" data-ts=\"1384264455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRG\" target=\"_blank\">NRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406092-nrg-energy-cuts-2013minus-14-outlook-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NRG Energy cuts 2013-14 outlook, shares slide</a></h4><ul>     <li>NRG Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/NRG\" title=\"NRG Energy, Inc.\">NRG</a>) <font color=\"red\">-2.8%</font> premarket even after its <a href=\"https://seekingalpha.com/currents/post/1405242\" target=\"_blank\">Q3 earnings</a> report enjoyed a boost from last year's GenOn Energy acquisition.</li>     <li>For the year, NRG lowered the high end of its previous EBITDA guidance range by $100M to $2.55B-$2.6B; for 2014, EBITDA guidance is cut to $2.7B-$2.9B from its previous estimate of $2.85B-$3.05B, primarily due to the decline in forward curves across core wholesale regions over the past few months as a result of the lack of scarcity pricing during the summer of 2013.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406092\" data-linked=\"NRG Energy cuts 2013-14 outlook, shares slide\" data-tweet=\"$NRG - NRG Energy cuts 2013-14 outlook, shares slide https://seekingalpha.com/news/1406092-nrg-energy-cuts-2013minus-14-outlook-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1406092-nrg-energy-cuts-2013minus-14-outlook-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406012\" data-ts=\"1384263580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOC\" target=\"_blank\">IOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406012-interoil-higher-after-reporting-q3-loss-papua-new-guinea-news-by-year-end\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterOil higher after reporting Q3 loss, Papua New Guinea news by year-end</a></h4><ul>     <li>InterOil (NYSE:<a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a>) <font color=\"green\">+4.5%</font> premarket after reporting a <a href=\"https://seekingalpha.com/currents/post/1404302\" target=\"_blank\">Q3 loss</a> but with better than expected revenues.</li>     <li>On Papua New Guinea: \"Negotiations with a number of supermajors regarding the monetization of  our gas resources are in the final stages. We expect to be able to make an announcement on the selection of our development partner before year-end.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1406012\" data-linked=\"InterOil higher after reporting Q3 loss, Papua New Guinea news by year-end\" data-tweet=\"$IOC - InterOil higher after reporting Q3 loss, Papua New Guinea news by year-end https://seekingalpha.com/news/1406012-interoil-higher-after-reporting-q3-loss-papua-new-guinea-news-by-year-end?source=tweet\" data-url=\"https://seekingalpha.com/news/1406012-interoil-higher-after-reporting-q3-loss-papua-new-guinea-news-by-year-end\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1406002\" data-ts=\"1384263546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1406002-fda-staff-supports-vandas-tasimelteon-ahead-of-panel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA staff supports Vanda&#39;s tasimelteon ahead of panel</a></h4><ul>\n<li>Vanda Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a>) is setting up for a big day, rising<strong> <font color=\"green\">88%</font></strong> in premarket trading.</li>\n<li>Briefing docs for Thursday's <a href=\"https://seekingalpha.com/currents/search?query=tasimelteon\" target=\"_blank\">tasimelteon</a> Ad Com suggest the Non-24-Hour Disorder treatment is safe and effective enough for FDA approval.</li>\n<li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM374385.pdf\" target=\"_blank\">Full documents</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1406002\" data-linked=\"FDA staff supports Vanda&#39;s tasimelteon ahead of panel\" data-tweet=\"$VNDA - FDA staff supports Vanda&#39;s tasimelteon ahead of panel https://seekingalpha.com/news/1406002-fda-staff-supports-vandas-tasimelteon-ahead-of-panel?source=tweet\" data-url=\"https://seekingalpha.com/news/1406002-fda-staff-supports-vandas-tasimelteon-ahead-of-panel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405922\" data-ts=\"1384262957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405922-hanwha-minus-13-percent-premarket-following-q3-report-margins-remain-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha -13% premarket following Q3 report; margins remain low</a></h4><ul>\n<li>While many Chinese solar names have seen their gross margins rebound to double-digit levels, Hanwha (HSOL) had a Q3 GM of just 5.1%. That's down from a Q2 level of 5.5%, albeit up from the year-ago period's -5.8%.</li>\n<li>Also: Hanwha's cash balance fell to $171.5M from $231.1M at the end of Q2. Debt totaled $791M vs. $791.7M at the end of Q2. Short-term debt amounted to $206.9M.</li>\n<li>Module shipments fell 1.1% Q/Q to 317.8MW (in-line with guidance of 300-325MW). Hanwha expects Q4 shipments of 360-380MW, and is reiterating guidance for full-year shipments of 1.2-1.4GW.</li>\n<li>Japan accounted for 46% of module shipments, up from 34% in Q2. The U.S. and China respectively made up 12% and 11%, up from a prior 7% and 4%. South Africa's shipment share was halved to 10%.</li>\n<li>Module ASP rose to RMB4.16/watt ($0.68/watt) from RMB4.03/watt in Q2, but was down from RMB 4.22/watt in the year-ago period. Q4 ASPs are expected to be \"stable to up.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1405012\" target=\"_blank\">Q3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1405922\" data-linked=\"Hanwha -13% premarket following Q3 report; margins remain low\" data-tweet=\"$HQCL - Hanwha -13% premarket following Q3 report; margins remain low https://seekingalpha.com/news/1405922-hanwha-minus-13-percent-premarket-following-q3-report-margins-remain-low?source=tweet\" data-url=\"https://seekingalpha.com/news/1405922-hanwha-minus-13-percent-premarket-following-q3-report-margins-remain-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405892\" data-ts=\"1384262766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405892-dendreon-announces-cost-cutting-measures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dendreon announces cost cutting measures</a></h4><ul>\n<li>Revenue falls 12.8% Y/Y for Dendreon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a>) during Q3, as the company <a href=\"https://seekingalpha.com/currents/post/1405742\" target=\"_blank\">misses estimates</a> on the top-line.</li>\n<li>CEO John Johnson announces a restructuring that he says is consistent with \"accelerating the path to profitability.\"</li>\n<li>According to DNDN, the plan will save around $125M in operating expenses versus the 2013 run rate.</li>\n<li>\"All expense categories\" will be affected as COGS should fall by around $30M and the total number of DNDN employees is expected to be ~820, \"down from more than 2,000 at [the company's] peak.\" (PR)</li>\n<li>Shares are getting a modest bump, up <font color=\"green\">2.5%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1405892\" data-linked=\"Dendreon announces cost cutting measures\" data-tweet=\"$DNDN - Dendreon announces cost cutting measures https://seekingalpha.com/news/1405892-dendreon-announces-cost-cutting-measures?source=tweet\" data-url=\"https://seekingalpha.com/news/1405892-dendreon-announces-cost-cutting-measures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405862\" data-ts=\"1384262320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405862-dish-network-rallies-post-earnings-conference-call-should-be-lively\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network rallies post-earnings, conference call should be lively</a></h4><ul> <li>Shares of Dish Network (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a>) trade higher after the company swung to a profit in Q3 and handily beat estimates for its subscriber count.</li> <li>Today's earnings call with Dish CEO Charlie Ergen should be lively with questions on the $3B worth of wireless spectrum the company has stockpiled sure to be asked along with inquiries on his latest stance on a merger with DirecTV.</li> <li>Previous: <a href=\"https://seekingalpha.com/currents/post/1404992\" target=\"_blank\">earnings</a>, <a href=\"https://seekingalpha.com/currents/post/1405182\" target=\"_blank\">details</a>\n</li>  <li>\n<a href=\"http://dish.client.shareholder.com/eventdetail.cfm?eventid=136591\" target=\"_blank\">Earnings call webcast</a> scheduled for 12:00 p.m. ET.</li> <li>DISH <font color=\"green\">+4.2%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1405862\" data-linked=\"Dish Network rallies post-earnings, conference call should be lively\" data-tweet=\"$DISH - Dish Network rallies post-earnings, conference call should be lively https://seekingalpha.com/news/1405862-dish-network-rallies-post-earnings-conference-call-should-be-lively?source=tweet\" data-url=\"https://seekingalpha.com/news/1405862-dish-network-rallies-post-earnings-conference-call-should-be-lively\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405832\" data-ts=\"1384262088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMX\" target=\"_blank\">CBMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405832-combimatrix-inks-deal-with-blue-cross-and-blue-shield-of-kansas-city\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CombiMatrix inks deal with Blue Cross and Blue Shield of Kansas City</a></h4><ul>\n<li>CombiMatrix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a>) jumps <font color=\"green\">10%</font> in premarket trading after announcing a contract with Blue Cross and Blue Shield of Kansas City.</li>\n<li>The deal provides coverage for CBMX's services to some 800K members. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1405832\" data-linked=\"CombiMatrix inks deal with Blue Cross and Blue Shield of Kansas City\" data-tweet=\"$CBMX - CombiMatrix inks deal with Blue Cross and Blue Shield of Kansas City https://seekingalpha.com/news/1405832-combimatrix-inks-deal-with-blue-cross-and-blue-shield-of-kansas-city?source=tweet\" data-url=\"https://seekingalpha.com/news/1405832-combimatrix-inks-deal-with-blue-cross-and-blue-shield-of-kansas-city\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405802\" data-ts=\"1384261788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405802-sarepta-shares-nearly-halve-as-fda-questions-dystrophin-6mwt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta shares nearly halve as FDA questions dystrophin, 6MWT</a></h4><ul>\n<li>Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) continues to tumble in premarket trading \u2014 shares are now down more than <strong><font color=\"red\">45%</font></strong>.</li>\n<li>The FDA came down particularly hard on dystrophin's ability to predict clinical benefit: \"The disconnect between increased expression of dystrophin and clinical efficacy for <a href=\"https://seekingalpha.com/currents/search?query=drisapersen\" target=\"_blank\">drisapersen</a> ... raises considerable doubt about the biomarker,\" the regulator says, adding that \"the quantity of dystrophin that might be necessary to be considered  reasonably likely to predict clinical benefit is even less clear.\"</li>\n<li>Also questioned is the 6MWT: \"Recent natural history data in DMD indicate that a baseline 6MWT e350 meters predicts continued general stability for  such patients, not the 75- to 83-meter yearly decline [SRPT] suggests in the  meeting package.\" Even worse: \"The expected variability of 6MWT values appears sufficient to explain  differences between arms on which the post-hoc analysis was based.\"</li>\n<li>Bottom line: The FDA \"believes a placebo-controlled trial would be the most likely  method for developing interpretable evidence of efficacy for <a href=\"https://seekingalpha.com/currents/search?query=eteplirsen\" target=\"_blank\">eteplirsen</a>,  because efficacy endpoints in DMD are effort-dependent and susceptible  to bias.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1405802\" data-linked=\"Sarepta shares nearly halve as FDA questions dystrophin, 6MWT\" data-tweet=\"$SRPT - Sarepta shares nearly halve as FDA questions dystrophin, 6MWT https://seekingalpha.com/news/1405802-sarepta-shares-nearly-halve-as-fda-questions-dystrophin-6mwt?source=tweet\" data-url=\"https://seekingalpha.com/news/1405802-sarepta-shares-nearly-halve-as-fda-questions-dystrophin-6mwt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405752\" data-ts=\"1384261448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGE\" target=\"_blank\">YGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405752-yingli-minus-7_1-percent-premarket-following-mixed-q3-results-guidance-reiteration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yingli -7.1% premarket following mixed Q3 results, guidance reiteration</a></h4><ul>\n<li>Yingli (NYSE:<a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a>) is reiterating its full-year module shipment guidance of 3.2GW-3.3GW. Given Yingli's <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1383771600000&amp;chddm=87880&amp;chls=IntervalBasedLine&amp;q=NYSE:YGE&amp;ntsp=1&amp;ei=1CKCUpj3Kci20AHBAw\" target=\"_blank\">big YTD gains</a>, as well as <a href=\"https://seekingalpha.com/currents/post/1382312\" target=\"_blank\">recent guidance hikes</a> from other Chinese solar names, investors may have wanted more.</li>\n<li>Thanks to stabilizing module prices and cost cuts, Q3 gross margin was 13.7%. That figure exceeds guidance of 11%-13%, and is up from 11.8% in Q2 and <em>-22.7% a year ago</em>.</li>\n<li>Chinese sales made up 38% of revenue, up from 28% in Q2, shipments to high-margin Japan (rising for many Chinese solar names) rose 35% Q/Q, and U.S. sales eclipsed European sales. European demand declined due to the import quota agreement reached between China and the EU. Chinese + U.S. sales equaled over half of revenue for the first time.</li>\n<li>Solar system sales jumped 368% Q/Q. Chinese module vendors are <a href=\"http://www.reuters.com/article/2013/11/07/us-china-solar-diversification-idUSBRE9A61B520131107\" target=\"_blank\">increasingly joining</a> their U.S. peers in expanding into solar project sales.</li>\n<li>Due to higher R&amp;D and G&amp;A spend, opex was $93M, +8% Q/Q and +34% Y/Y.</li>\n<li>Yingli's cash balance fell to $442.7M from $591M at the end of Q2. However, debt fell to $2.6B from $2.8B.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1405522\" target=\"_blank\">Q3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1405752\" data-linked=\"Yingli -7.1% premarket following mixed Q3 results, guidance reiteration\" data-tweet=\"$YGE - Yingli -7.1% premarket following mixed Q3 results, guidance reiteration https://seekingalpha.com/news/1405752-yingli-minus-7_1-percent-premarket-following-mixed-q3-results-guidance-reiteration?source=tweet\" data-url=\"https://seekingalpha.com/news/1405752-yingli-minus-7_1-percent-premarket-following-mixed-q3-results-guidance-reiteration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405482\" data-ts=\"1384259318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405482-fda-too-early-for-sarepta-to-file-for-approval-of-eteplirsen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA: Too early for Sarepta to file for approval of Eteplirsen</a></h4><ul>   <li>The FDA says that Sarepta's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) submission of a New Drug Application (NDA) for the company's <a href=\"https://seekingalpha.com/currents/search?query=Eteplirsen\" target=\"_blank\">Eteplirsen drug</a> for the treatment of Duchenne muscular dystrophy (DMD) is premature following the failure of GlaxoSmithKline's and Prosensa's Drisapersen product in a Phase III trial.</li>    <li>The FDA also indicated that - in Sarepta's words - \"new data raise 'considerable doubt' about the dystrophin biomarker and the supportive clinical efficacy assessed on the 6-minute walk test (6MWT) in the Phase IIb clinical study of Eteplirsen.\"</li>    <li>Last month, SA author EnhydrisPECorp <a href=\"https://seekingalpha.com/article/1786112-short-sarepta-dmd-drug-prognosis-is-dismal\" target=\"_blank\">predicted </a>that the FDA wouldn't grant early approval of Eteplirsen.</li>    <li>Shares are <font color=\"red\">-29%.</font> (PR) (<a href=\"https://seekingalpha.com/currents/post/1405282\" target=\"_blank\">Q3 results</a>)</li>      </ul><div class=\"tiny-share-widget\" data-id=\"1405482\" data-linked=\"FDA: Too early for Sarepta to file for approval of Eteplirsen\" data-tweet=\"$SRPT - FDA: Too early for Sarepta to file for approval of Eteplirsen https://seekingalpha.com/news/1405482-fda-too-early-for-sarepta-to-file-for-approval-of-eteplirsen?source=tweet\" data-url=\"https://seekingalpha.com/news/1405482-fda-too-early-for-sarepta-to-file-for-approval-of-eteplirsen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1405322\" data-ts=\"1384258107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1405322-gsk-heart-treatment-fails-in-phase-iii-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSK heart treatment fails in Phase III trial</a></h4><ul>   <li>GSK's (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) darapladib treatment <a href=\"http://online.wsj.com/article/SB10001424052702303460004579193250971582892.html\" target=\"_blank\">failed to reduce</a> the risk of heart attack or stroke among chronic-heart-disease patients in the first of two Phase III trials.</li>    <li>GSK acquired the rights to darapladib when it bought Human Genome Sciences for $3B in 2012.</li>    <li>In the study of over 1,500 patients, darapladib was no better than a placebo in cutting the time prior to a heart attack, stroke or death.</li>    <li>However, darapladib did bring about a reduction in some coronary events, although GSK didn't provide details.</li>    <li>Analyst Savvas Neophytou expects GSK to take a writedown of £150M ($239M) in Q4 because of the failure of darapladib.</li>    <li>Shares are <font color=\"red\">-2.2%</font> premarket. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1405322\" data-linked=\"GSK heart treatment fails in Phase III trial\" data-tweet=\"$GSK - GSK heart treatment fails in Phase III trial https://seekingalpha.com/news/1405322-gsk-heart-treatment-fails-in-phase-iii-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1405322-gsk-heart-treatment-fails-in-phase-iii-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404892\" data-ts=\"1384251713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404892-asian-shares-mixed-europe-stocks-and-u-s-futures-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares mixed, Europe stocks and U.S. futures lower</a></h4><ul>     <li>European equities have stayed lower following <a href=\"https://seekingalpha.com/currents/search?query=october%20cpi\" target=\"_blank\">tame inflation reports</a> from Germany, Italy and the U.K.</li>     <li>Earlier, Japanese stocks <font color='green'>rose 2.2%</font> as the yen weakened sharply against the dollar, with last week's strong U.S. jobs report still apparently <a href=\"http://online.wsj.com/news/articles/SB10001424052702303914304579192551666342342\" target=\"_blank\">boosting the greenback.<br>     </a></li>     <li>Chinese stocks <font color='green'>increased 0.8%</font> as investors <a href=\"https://seekingalpha.com/currents/post/1404852\" target=\"_blank\">awaited the outcome</a> of a major meeting of Communist Party leaders, although Hong Kong <font color='red'>fell 0.8%</font>.</li>     <li>India <font color='red'>-1%</font>.</li>     <li>EU Stoxx 50 <font color='red'>-0.3%</font>, London <font color='red'>-0.2%</font>, Paris <font color='red'>-0.2%</font>, Frankfurt <font color='red'>-0.2%</font>, Milan <font color='red'>-0.2%</font>, Madrid <font color='red'>-0.75%</font>.</li><li>U.S. stock futures: Dow <font color='red'>-0.1%</font>. S&amp;P <font color='red'>-0.2%</font>. Nasdaq <font color='red'>-0.2%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"1404892\" data-linked=\"Asian shares mixed, Europe stocks and U.S. futures lower\" data-tweet=\"Asian shares mixed, Europe stocks and U.S. futures lower https://seekingalpha.com/news/1404892-asian-shares-mixed-europe-stocks-and-u-s-futures-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1404892-asian-shares-mixed-europe-stocks-and-u-s-futures-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1404882\" data-ts=\"1384250615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1404882-u-k-inflation-drops-towards-boe-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.K. inflation drops towards BOE target</a></h4><ul>     <li>\n<a href=\"http://www.businessweek.com/news/2013-11-12/u-dot-k-dot-inflation-slows-more-than-forecast-to-least-in-a-year\" target=\"_blank\">U.K. CPI</a> slowed to +0.1% on month in October from +0.4% in September and was below consensus of +0.3%.</li>     <li>On year, inflation dropped to 2.2% from 2.7% and vs forecasts of 2.5%.</li>     <li>Core CPI +1.7%.</li>     <li>The drop in annual overall inflation moves the metric closer to the Bank of England's target of 2%. \"Low inflation should allow monetary policy to continue to support a strong economic recovery in 2014-15,\" says Citigroup economist Michael Saunders.</li>     <li>Lower transport costs, including for motor fuels and air fares, and university tuition fees, provided the largest downward pressure on prices.</li>     <li>Factory output prices (PPI) fell 0.3% on month, the largest decline since June 2012.</li>     <li>The pound slides vs the dollar and is <font color=\"red\">-0.7%</font> at $1.5872, while the FTSE 100 is <font color=\"red\">-0.2%</font>. (PR)</li>\n<li>ETFs - Stocks: <a href=\"https://seekingalpha.com/symbol/fku\" title=\"First Trust United Kingdom AlphaDex ETF\">FKU</a>, <a href=\"https://seekingalpha.com/symbol/ewu\" title=\"iShares MSCI United Kingdom ETF\">EWU</a>, <a href=\"https://seekingalpha.com/symbol/ewus\" title=\"iShares MSCI United Kingdom Small Cap Index ETF\">EWUS</a>, <a href=\"https://seekingalpha.com/symbol/dxps\" title=\"WisdomTree United Kingdom Hedged Equity ETF\">DXPS</a>. Currency: <a href=\"https://seekingalpha.com/symbol/gbb\" title=\"iPath GBP/USD Exchange Rate ETN\">GBB</a>, <a href=\"https://seekingalpha.com/symbol/fxb\" title=\"CurrencyShares British Pound Sterling Trust ETF\">FXB</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1404882\" data-linked=\"U.K. inflation drops towards BOE target\" data-tweet=\"$FKU $EWU $EWUS - U.K. inflation drops towards BOE target https://seekingalpha.com/news/1404882-u-k-inflation-drops-towards-boe-target?source=tweet\" data-url=\"https://seekingalpha.com/news/1404882-u-k-inflation-drops-towards-boe-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 AM </div></div></li>","count":71,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}